HP INC, 10-Q filed on 8/27/2026
Quarterly Report
v3.26.1
Cover Page - shares
9 Months Ended
Jul. 31, 2026
Aug. 19, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jul. 31, 2026  
Document Transition Report false  
Entity File Number 1-4423  
Entity Registrant Name HP INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 94-1081436  
Entity Address, Address Line One 1501 Page Mill Road  
Entity Address, City or Town Palo Alto,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94304  
City Area Code 650  
Local Phone Number 857-1501  
Title of 12(b) Security Common stock, par value $0.01 per share  
Trading Symbol HPQ  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   901,790,969
Entity Central Index Key 0000047217  
Amendment Flag false  
Current Fiscal Year End Date --10-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
v3.26.1
Condensed Consolidated Statements of Earnings (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Net revenue:        
Total net revenue $ 15,677 $ 13,932 $ 44,523 $ 40,656
Cost of net revenue:        
Total cost of net revenue 12,732 11,081 35,727 32,226
Gross profit 2,945 2,851 8,796 8,430
Research and development 389 406 1,213 1,204
Selling, general and administrative 1,537 1,452 4,555 4,391
Restructuring and other charges 48 110 539 302
Acquisition and divestiture charges 4 8 6 31
Amortization of intangible assets 75 159 220 287
Total operating expenses 2,053 2,135 6,533 6,215
Earnings from operations 892 716 2,263 2,215
Interest and other, net (94) (92) (301) (381)
Earnings before taxes 798 624 1,962 1,834
(Provision for) benefit from taxes (137) 139 (306) (100)
Net earnings $ 661 $ 763 $ 1,656 $ 1,734
Net earnings per share:        
Basic (usd per share) $ 0.72 $ 0.81 $ 1.80 $ 1.83
Diluted (usd per share) $ 0.71 $ 0.80 $ 1.79 $ 1.82
Weighted-average shares used to compute net earnings per share:        
Basic (in shares) 919 947 922 948
Diluted (in shares) 927 954 927 955
Products        
Net revenue:        
Total net revenue $ 14,825 $ 13,114 $ 41,986 $ 38,232
Cost of net revenue:        
Total cost of net revenue 12,256 10,599 34,312 30,800
Services        
Net revenue:        
Total net revenue 852 818 2,537 2,424
Cost of net revenue:        
Total cost of net revenue $ 476 $ 482 $ 1,415 $ 1,426
v3.26.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Statement of Comprehensive Income [Abstract]        
Net earnings $ 661 $ 763 $ 1,656 $ 1,734
Change in unrealized components of available-for-sale debt securities:        
Unrealized gains arising during the period 1 5 2 11
Change in unrealized components of cash flow hedges:        
Unrealized gains (losses) arising during the period 141 59 (6) (301)
Losses reclassified into earnings 18 202 119 11
Change in unrealized components of cash flow hedges 159 261 113 (290)
Change in unrealized components of defined benefit plans:        
Unrealized gains (losses) arising during the period 20 (7) (14) (8)
Amortization of actuarial loss and prior service benefit 5 5 14 15
Curtailments, settlements and other 3 2 5 2
Change in unrealized components of defined benefit plans 28 0 5 9
Change in cumulative translation adjustment (3) (1) 11 16
Other comprehensive income (loss) before taxes 185 265 131 (254)
(Provision for) benefit from taxes (32) (63) (22) 47
Other comprehensive income (loss), net of taxes 153 202 109 (207)
Comprehensive income $ 814 $ 965 $ 1,765 $ 1,527
v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Current assets:    
Cash, cash equivalents and restricted cash $ 4,169 $ 3,705
Accounts receivable, net of allowance for credit losses of $57 and $83 as of July 31, 2026 and October 31, 2025 7,168 5,692
Inventory 10,322 8,512
Other current assets 5,087 4,544
Total current assets 26,746 22,453
Property, plant and equipment, net 3,110 3,049
Goodwill 8,726 8,706
Other non-current assets 7,119 7,561
Total assets 45,701 41,769
Current liabilities:    
Notes payable and short-term borrowings 1,292 845
Accounts payable 21,383 18,051
Other current liabilities 11,288 10,362
Total current liabilities 33,963 29,258
Long-term debt 7,868 8,821
Other non-current liabilities 3,962 4,036
Stockholders’ deficit:    
Preferred stock, $0.01 par value (300 shares authorized; none issued) 0 0
Common stock, $0.01 par value (9,600 shares authorized; 903 and 921 shares issued and outstanding as of July 31, 2026 and October 31, 2025) 9 9
Additional paid-in capital 2,364 2,129
Accumulated deficit (2,117) (2,027)
Accumulated other comprehensive loss (348) (457)
Total stockholders’ deficit (92) (346)
Total liabilities and stockholders’ deficit $ 45,701 $ 41,769
v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Statement of Financial Position [Abstract]    
Accounts receivable, net of allowance for credit losses $ 57 $ 83
Preferred stock, par value (usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 300,000,000 300,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 9,600,000,000 9,600,000,000
Common stock, shares issued (in shares) 903,000,000 921,000,000
Common stock, shares outstanding (in shares) 903,000,000 921,000,000
v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities:    
Net earnings $ 1,656 $ 1,734
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation, amortization and impairment 722 708
Stock-based compensation expense 389 432
Restructuring and other charges 539 302
Deferred taxes on earnings (110) (67)
Other, net 126 103
Changes in operating assets and liabilities, net of divestitures:    
Accounts receivable (1,531) 54
Inventory (1,902) (671)
Accounts payable 3,323 94
Net investment in leases from integrated financing (69) (71)
Taxes on earnings (184) (360)
Restructuring and other (256) (238)
Other assets and liabilities 341 53
Net cash provided by operating activities 3,044 2,073
Cash flows from investing activities:    
Investment in property, plant, equipment and purchased intangibles (590) (700)
Purchases of available-for-sale securities and other investments (21) (23)
Maturities and sales of available-for-sale securities and other investments 32 69
Collateral returned (posted) for derivative instruments 98 (343)
Payments made in connection with business acquisitions, net of cash acquired (10) (116)
Proceeds from business divestitures, net 26 0
Net cash used in investing activities (465) (1,113)
Cash flows from financing activities:    
Proceeds from debt, net of issuance costs 291 1,248
Payment of debt (770) (1,312)
Stock-based award activities and others (94) (113)
Repurchase of common stock (725) (350)
Cash dividends paid (825) (818)
Settlement of cash flow hedges 0 6
Net cash used in financing activities (2,123) (1,339)
Increase (decrease) in cash, cash equivalents and restricted cash 456 (379)
Cash, cash equivalents and restricted cash at beginning of period [1] 3,713 3,253
Cash, cash equivalents and restricted cash at end of period $ 4,169 $ 2,874
[1] Includes cash held for sale of $8 million recorded within Other current assets as of October 31, 2025
v3.26.1
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2024   938,989      
Balance at the beginning of period at Oct. 31, 2024 $ (1,323) $ 9 $ 1,778 $ (2,676) $ (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 565     565  
Other comprehensive income (loss), net of taxes 230       230
Comprehensive income (loss) 795        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,405      
Issuance of common stock in connection with employee stock plans and other (92)   (92)    
Repurchases of common stock (in shares)   (2,734)      
Repurchases of common stock (Note 9) (97)   (4) (93)  
Cash dividends (547)     (547)  
Stock-based compensation expense 192   192    
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the end of period at Jan. 31, 2025 (1,072) $ 9 1,874 (2,751) (204)
Balance (in shares) at Oct. 31, 2024   938,989      
Balance at the beginning of period at Oct. 31, 2024 (1,323) $ 9 1,778 (2,676) (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,734        
Other comprehensive income (loss), net of taxes (207)        
Comprehensive income (loss) $ 1,527        
Repurchases of common stock (in shares) (11,400)        
Balance (in shares) at Jul. 31, 2025   938,765      
Balance at the end of period at Jul. 31, 2025 $ (901) $ 9 2,091 (2,360) (641)
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the beginning of period at Jan. 31, 2025 (1,072) $ 9 1,874 (2,751) (204)
Increase (Decrease) in Stockholders' Equity          
Net earnings 406     406  
Other comprehensive income (loss), net of taxes (639)       (639)
Comprehensive income (loss) (233)        
Issuance of common stock in connection with employee stock plans and other (in shares)   667      
Issuance of common stock in connection with employee stock plans and other (9)   (9)    
Repurchases of common stock (in shares)   (3,118)      
Repurchases of common stock (Note 9) (103)   (6) (97)  
Cash dividends 1     1  
Stock-based compensation expense 140   140    
Balance (in shares) at Apr. 30, 2025   942,209      
Balance at the end of period at Apr. 30, 2025 (1,276) $ 9 1,999 (2,441) (843)
Increase (Decrease) in Stockholders' Equity          
Net earnings 763     763  
Other comprehensive income (loss), net of taxes 202       202
Comprehensive income (loss) 965        
Issuance of common stock in connection with employee stock plans and other (in shares)   2,057      
Issuance of common stock in connection with employee stock plans and other $ 5   5    
Repurchases of common stock (in shares) (5,500) (5,501)      
Repurchases of common stock (Note 9) $ (152)   (13) (139)  
Cash dividends (543)     (543)  
Stock-based compensation expense 100   100    
Balance (in shares) at Jul. 31, 2025   938,765      
Balance at the end of period at Jul. 31, 2025 $ (901) $ 9 2,091 (2,360) (641)
Balance (in shares) at Oct. 31, 2025 921,000 921,149      
Balance at the beginning of period at Oct. 31, 2025 $ (346) $ 9 2,129 (2,027) (457)
Increase (Decrease) in Stockholders' Equity          
Net earnings 545     545  
Other comprehensive income (loss), net of taxes (197)       (197)
Comprehensive income (loss) 348        
Issuance of common stock in connection with employee stock plans and other (in shares)   9,385      
Issuance of common stock in connection with employee stock plans and other (73)   (73)    
Repurchases of common stock (in shares)   (13,360)      
Repurchases of common stock (Note 9) (325)   (31) (294)  
Cash dividends (552)     (552)  
Stock-based compensation expense 182   182    
Balance (in shares) at Jan. 31, 2026   917,174      
Balance at the end of period at Jan. 31, 2026 $ (766) $ 9 2,207 (2,328) (654)
Balance (in shares) at Oct. 31, 2025 921,000 921,149      
Balance at the beginning of period at Oct. 31, 2025 $ (346) $ 9 2,129 (2,027) (457)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,656        
Other comprehensive income (loss), net of taxes 109        
Comprehensive income (loss) $ 1,765        
Repurchases of common stock (in shares) (30,500)        
Balance (in shares) at Jul. 31, 2026 903,000 903,409      
Balance at the end of period at Jul. 31, 2026 $ (92) $ 9 2,364 (2,117) (348)
Balance (in shares) at Jan. 31, 2026   917,174      
Balance at the beginning of period at Jan. 31, 2026 (766) $ 9 2,207 (2,328) (654)
Increase (Decrease) in Stockholders' Equity          
Net earnings 450     450  
Other comprehensive income (loss), net of taxes 153       153
Comprehensive income (loss) 603        
Issuance of common stock in connection with employee stock plans and other (in shares)   2,213      
Issuance of common stock in connection with employee stock plans and other (2)   (2)    
Repurchases of common stock (in shares)   (4,977)      
Repurchases of common stock (Note 9) (95)   (12) (83)  
Cash dividends 1     1  
Stock-based compensation expense 115   115    
Balance (in shares) at Apr. 30, 2026   914,410      
Balance at the end of period at Apr. 30, 2026 (144) $ 9 2,308 (1,960) (501)
Increase (Decrease) in Stockholders' Equity          
Net earnings 661     661  
Other comprehensive income (loss), net of taxes 153       153
Comprehensive income (loss) 814        
Issuance of common stock in connection with employee stock plans and other (in shares)   1,195      
Issuance of common stock in connection with employee stock plans and other $ (11)   (11)    
Repurchases of common stock (in shares) (12,200) (12,196)      
Repurchases of common stock (Note 9) $ (303)   (32) (271)  
Cash dividends (547)     (547)  
Stock-based compensation expense $ 99   99    
Balance (in shares) at Jul. 31, 2026 903,000 903,409      
Balance at the end of period at Jul. 31, 2026 $ (92) $ 9 $ 2,364 $ (2,117) $ (348)
v3.26.1
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) (Parenthetical) - $ / shares
3 Months Ended
Jul. 31, 2026
Jan. 31, 2026
Jul. 31, 2025
Jan. 31, 2025
Statement of Stockholders' Equity [Abstract]        
Cash dividends per share (usd per share) $ 0.60 $ 0.60 $ 0.58 $ 0.58
v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)
$ in Millions
Oct. 31, 2025
USD ($)
Statement of Cash Flows [Abstract]  
Cash, held-for-sale $ 8
v3.26.1
Basis of Presentation
9 Months Ended
Jul. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation
Basis of Presentation
The accompanying Condensed Consolidated Financial Statements of HP and its wholly owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2025 in HP’s Annual Report on Form 10-K, filed on December 13, 2025. The Condensed Consolidated Balance Sheet for October 31, 2025 was derived from audited financial statements.
Principles of Consolidation
The Condensed Consolidated Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Reclassifications
HP has reclassified certain prior-year amounts to conform to the current-year presentation.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Issued Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued guidance that requires disaggregation of specific expense categories in disclosures within the footnotes to the financial statements on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2028 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. The Company will adopt the guidance prospectively. Adoption of this new guidance will result in additional disclosures in the “Taxes on Earnings” note in the Company’s Consolidated Financial Statements but will not impact the consolidated financial results.
v3.26.1
Segment Information
9 Months Ended
Jul. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
HP has three reportable segments: Personal Systems, Printing, and Corporate Investments.
Personal Systems offers desktops, notebooks, and workstations (including HP’s portfolio of AI PCs and workstations), thin clients, retail point-of-sale (“POS”) systems, displays, hybrid systems, software, solutions including endpoint security and services. Personal Systems includes support and deployment, configurations, and extended warranty services. HP supports a multi-operating system and multi-architecture strategy, primarily using Microsoft Windows and Google Chrome operating systems. HP’s platforms incorporate processors from Intel, AMD and Qualcomm, including integrated AI acceleration, as well as NVIDIA GPUs for advanced graphics and compute workloads.
Personal Systems groups its global business capabilities into the following business units when reporting business performance:
•Commercial PS consists of endpoint computing devices and hybrid systems, for use by enterprise, public sector (which includes education), and small- and medium-sized business (“SMB”) customers. These devices include HP’s Pro and Elite commercial PC portfolio, HP’s Z line of workstations, thin clients, retail POS systems, and HP’s Dragonfly and Chromebook PCs. HP offers a range of secure services and solutions to commercial customers to help them manage the lifecycle of their PCs and mobility installed base.
•    Consumer PS consists of devices, accessories and services which are optimized for consumer usage, focusing on gaming, learning and working remotely, consuming multi-media for entertainment, managing personal life activities, sharing information and staying connected, informed, and secure. These devices include HP’s new Omni consumer PC portfolio, the Omen and Victus gaming lines, and HP’s Spectre, Envy, Pavilion and Chromebook PCs.
Printing provides consumer and commercial printer hardware, supplies, services and solutions. Printing is also focused on Graphics and 3D Printing and Personalization in the commercial and industrial markets. HP’s global business capabilities within Printing are described below:
•Office Printing Solutions delivers HP’s security enhanced office printers, supplies, services, and solutions to SMBs, public sector and large enterprises. It also includes Original Equipment Manufacturer (“OEM”) hardware and solutions.
•Home Printing Solutions delivers innovative and security enhanced printing products, supplies, services and solutions for the home, home business and micro business customers.
•Graphics Solutions delivers large-format, commercial and industrial solutions and supplies to print service providers and packaging converters through a wide portfolio of printers and presses.
•3D Printing & Personalization offers a portfolio of additive manufacturing solutions and supplies to help customers succeed in their additive and digital manufacturing journey. HP offers complete solutions in collaboration with an ecosystem of partners.
Printing groups its global business capabilities into the following business units when reporting business performance:
•Commercial Printing consists of office printing solutions, graphics solutions and 3D printing and personalization, excluding supplies;
•Consumer Printing consists of home printing solutions, excluding supplies; and
•Supplies comprises a set of highly innovative consumable products, ranging from ink and laser cartridges to media, industrial graphics supplies and 3D printing and personalization supplies, for recurring use in consumer and commercial hardware.
Corporate Investments includes certain business incubation projects and investments in digital enablement.
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges, amortization of intangible assets, and certain litigation (charges) benefits, net.
Significant Segment Expenses and Operating Results
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Net revenue
Commercial PS$8,579 $7,036 $23,575 $20,467 
Consumer PS3,188 2,895 8,656 7,712 
Personal Systems11,767 9,931 32,231 28,179 
Supplies2,536 2,609 8,089 8,166 
Commercial Printing1,101 1,113 3,374 3,424 
Consumer Printing275 280 831 889 
Printing3,912 4,002 12,294 12,479 
Corporate Investments— — — — 
Total segment net revenue15,679 13,933 44,525 40,658 
Other(2)(1)(2)(2)
Total net revenue$15,677 $13,932 $44,523 $40,656 
Cost of net revenue
Personal Systems$10,250 $8,421 $27,785 $24,009 
Printing2,475 2,640 7,889 8,134 
Corporate Investments— — 1 2 
Total segment cost of net revenue12,725 11,061 35,675 32,145 
Operating expenses
Personal Systems$980 $969 $2,868 $2,713 
Printing728 681 2,164 2,059 
Corporate Investments28 24 80 67 
Total segment operating expenses1,736 1,674 5,112 4,839 
Earnings before taxes
Personal Systems$537 $541 $1,578 $1,457 
Printing709 681 2,241 2,286 
Corporate Investments(28)(24)(81)(69)
Total segment earnings from operations1,218 1,198 3,738 3,674 
Corporate and unallocated costs and other(102)(103)(258)(302)
Stock-based compensation expense(95)(100)(389)(432)
Restructuring and other charges(48)(110)(539)(302)
Acquisition and divestiture charges(4)(8)(6)(31)
Amortization of intangible assets(75)(159)(220)(287)
Certain litigation charges
(2)(2)(63)(105)
Interest and other, net(1)
(94)(92)(301)(381)
Total earnings before taxes$798 $624 $1,962 $1,834 
(1)    The three and nine months ended July 31, 2025 includes Certain litigation benefits from a single litigation matter that does not relate to HP's ongoing business operations.
Realignment
Effective at the beginning of its first quarter of fiscal year 2026, HP realigned its business unit financial reporting to reflect the transition of the Print-as-a-Service business from Corporate Investments to Printing. HP reflected this change to its business unit information in prior reporting periods on an as-if basis which resulted in the reclassification of segment net revenue, cost of net revenue and operating expenses from the Corporate Investments segment to Supplies and Consumer Printing. The reporting change had no impact to previously reported consolidated net revenue, earnings from operations, net earnings or net earnings per share (“EPS”). In connection with this business unit realignment, the Company reallocated $197 million of goodwill from Corporate Investments to Printing on a relative fair value basis. The realignment did not result in any impairments to goodwill in any of the affected reporting units.
v3.26.1
Restructuring and Other Charges
9 Months Ended
Jul. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring and Other Charges Restructuring and Other Charges
Summary of Restructuring Plans
Fiscal 2026 Plan
On November 25, 2025, HP’s Board of Directors approved the Fiscal 2026 Plan intended to drive customer satisfaction, product innovation, and productivity primarily through artificial intelligence adoption and enablement that HP expects will be implemented through fiscal 2028. HP expects to reduce global headcount by approximately 4,000 to 6,000 employees. HP estimates that it will incur pre-tax charges of approximately $650 million relating to labor and non-labor actions, and other charges. During the course of the Fiscal 2026 Plan, HP expects to incur approximately $500 million in labor costs related to workforce reductions and expects the remaining costs to relate to non-labor actions and other charges.
Fiscal 2023 Plan
On November 18, 2022, HP’s Board of Directors approved the Fiscal 2023 Plan intended to enable digital transformation, portfolio optimization and operational efficiency that HP implemented through fiscal 2025. The Fiscal 2023 Plan is substantially complete. HP does not expect any further significant costs associated with the plan. Approximately 9,500 employees departed as part of the plan through a combination of employee exits and voluntary Enhanced Early Retirement (“EER”). HP incurred $865 million in severance costs and $347 million in infrastructure costs related to non-labor and other charges.
HP’s restructuring and other charges under the Fiscal 2026 Plan and Fiscal 2023 Plan were as follows:

Fiscal 2026 Plan
Three months ended July 31, 2026Nine months ended July 31, 2026
Severance$38 $200 
Non-labor7 30 
Special Termination Benefit— 280 
Other charges(1)
15 37 
$60 $547 
Other prior plan costs(2)
(12)(8)
$48 $539 

Fiscal 2023 Plan
Three months ended July 31, 2025Nine months ended July 31, 2025
Severance$77 $218 
Non-labor14 34 
Other charges(1)
19 50 
$110 $302 

(1)     Other charges are distinct from ongoing operational costs and primarily include third-party professional services and other non-recurring costs, which include artificial intelligence adoption and enablement costs under the Fiscal 2026 Plan. Effective second quarter of fiscal 2026, other charges also includes CEO transition costs, which comprises of executive hiring and retention costs.

(2)    Other prior plans primarily include the Fiscal 2023 Plan, which is substantially complete. HP does not expect any further material activity associated with this plan.
The reconciliation of the beginning and ending liability balance showing activity during the year is as follows:
Fiscal 2026 Plan
Severance Non-laborOther prior-year plansTotal
In millions
Accrued balance as of October 31, 2025$— $— $172 $172 
Charges200 30 (8)222 
Cash payments(91)(13)(122)(226)
Non-cash and other adjustments— (17)2 (15)
Accrued balance as of July 31, 2026$109 $— $44 $153 
Reflected in the Condensed Consolidated Balance Sheets
Other current liabilities$76 $— $41 $117 
Other non-current liabilities$33 $— $3 $36 
Accrued balance as of October 31, 2024$— $— $138 $138 
Charges— — 252 252 
Cash payments— — (188)(188)
Non-cash and other adjustments— — (21)(21)
Accrued balance as of July 31, 2025$— $— $181 $181 
As of July 31, 2026, HP has incurred $0.5 billion and $1.2 billion of total costs for the Fiscal 2026 Plan and the Fiscal 2023 Plan, respectively.
Retirement Incentive Program
As part of the Fiscal 2026 Plan, HP announced a voluntary EER program for its U.S. employees in March 2026. Voluntary participation in the EER program was limited to employees at least 55 years old with 10 or more years of service at HP. Employees accepted into the EER program are leaving HP on dates ranging from May 29, 2026 to April 30, 2027. The U.S. defined benefit pension plan was amended to provide that the EER benefit will be paid from the plan for eligible electing EER participants.
The retirement incentive benefit is calculated as a lump sum based on years of service at HP at the time of retirement, ranging from 20 to 52 weeks of pay. As a result of this retirement incentive, HP recognized a Special Termination Benefit (“STB”) expense of $220 million as restructuring and other charges for the nine months ended July 31, 2026. The expense has been recorded as a reduction from the Prepaid pension and post-retirement benefit assets reflected under Other non-current assets in the Condensed Consolidated Balance Sheets.
All employees participating in the EER program were offered the opportunity to continue health care coverage at the active employee contribution rates for up to 36 months following retirement, but not beyond age 65 when Medicare is available. HP recognized an additional STB expense of $60 million as restructuring and other charges for the nine months ended July 31, 2026 for the health care incentives. The expense has been recorded in the Pension, post-retirement and post-employment liabilities reflected under Other non-current liabilities in the Condensed Consolidated Balance Sheets.
STB expense is a non-cash expense and represents the present value of all EER benefits that will be paid from the pension plan assets.
v3.26.1
Taxes on Earnings
9 Months Ended
Jul. 31, 2026
Income Tax Disclosure [Abstract]  
Taxes on Earnings Taxes on Earnings
Provision for Taxes
HP’s effective tax rate was 17.2% and (22.3)% for the three months ended July 31, 2026 and 2025, respectively, and 15.6% and 5.5% for the nine months ended July 31, 2026 and 2025, respectively. The difference between the U.S. federal statutory tax rate of 21% and HP’s effective tax rate for the three months ended July 31, 2026 was primarily due to decreases in unrecognized tax benefits. For the nine months ended July 31, 2026, the difference was primarily due to decreases in unrecognized tax benefits and audit settlements in various jurisdictions.
Uncertain Tax Positions
As of July 31, 2026, the amount of gross unrecognized tax benefits was $752 million, of which up to $615 million would affect HP’s effective tax rate if realized. Total gross unrecognized tax benefits decreased by $113 million for the nine months ended July 31, 2026. HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Condensed Consolidated Statements of Earnings. As of July 31, 2026 and October 31, 2025, HP had accrued $71 million and $122 million, respectively, for interest and penalties.
HP is subject to income tax in the United States and approximately 60 other countries and is subject to routine corporate income tax audits in many of these jurisdictions. In addition, HP is subject to numerous ongoing audits by federal, state and foreign tax authorities. The Internal Revenue Service (“IRS”) is conducting an audit of HP’s 2018 and 2019 income tax returns.
v3.26.1
Supplementary Financial Information
9 Months Ended
Jul. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplementary Financial Information Supplementary Financial Information
Cash, Cash Equivalents and Restricted Cash
As of
July 31, 2026October 31, 2025
In millions
Cash and cash equivalents$4,169 $3,690 
Restricted cash(1)
— 15 
$4,169 $3,705 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Accounts Receivable
The allowance for credit losses related to accounts receivable and changes were as follows:
Nine months ended July 31, 2026
In millions
Balance at beginning of period$83 
Current-period allowance for credit losses(18)
Deductions, net of recoveries(8)
Balance at end of period$57 
HP utilizes certain third-party arrangements in the normal course of business as part of HP’s cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Condensed Consolidated Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Condensed Consolidated Balance Sheets. The recourse obligations as of July 31, 2026 and October 31, 2025 were not material.
The following is a summary of the activity under these arrangements:
Three months ended July 31Nine months ended July 31
202620252026

2025
In millions
Balance at beginning of period(1)
$289 $217 $117 $284 
Trade receivables sold1,729 3,085 7,153 9,259 
Cash receipts(2,009)(3,184)(7,264)(9,431)
Foreign currency and other(5)2 (2)8 
Balance at end of period(1)
$4 $120 $4 $120 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Condensed Consolidated Balance Sheets.
Inventory
As of
July 31, 2026October 31, 2025
In millions
Finished goods$5,958 $4,721 
Purchased parts and fabricated assemblies4,364 3,791 
$10,322 $8,512 

Other Current Assets
As of
July 31, 2026October 31, 2025
In millions
Supplier and other receivables
$2,468 $1,981 
Prepaid and other current assets
1,486 1,577 
Value-added taxes receivable1,133 986 
$5,087 $4,544 

Property, Plant and Equipment, Net
As of
July 31, 2026October 31, 2025
In millions
Land, buildings and leasehold improvements$2,634 $2,619 
Machinery and equipment, including equipment held for lease6,251 5,867 
8,885 8,486 
Accumulated depreciation(5,775)(5,437)
$3,110 $3,049 

Other Non-Current Assets
As of
July 31, 2026October 31, 2025
In millions
Deferred tax assets$3,413 $3,318 
Right-of-use assets1,086 1,129 
Intangible assets(1)
802 1,012 
Prepaid pension and post-retirement benefit assets(2)
220 425 
Deposits and prepaid187 316 
Other1,411 1,361 
$7,119 $7,561 
(1)    During the three and nine months ended July 31, 2026, the Company incurred impairment charges of $23 million and $55 million related to acquired customer contracts, customer lists and distribution agreements and technology and patents related to the Personal Systems segment.
(2)    Decrease relates to the reclassification of EER benefits to be paid from the U.S. defined pension plan in connection with the Fiscal 2026 Plan. See Note 3 “Restructuring and Other Charges” for further information.
Other Current Liabilities
As of
July 31, 2026October 31, 2025
In millions
Sales and marketing programs$3,476 $3,103 
Deferred revenue1,761 1,609 
Other accrued taxes1,410 1,258 
Employee compensation and benefits1,272 965 
Operating lease liabilities409 401 
Warranty354 401 
Tax liability101 297 
Other2,505 2,328 
$11,288 $10,362 

Other Non-Current Liabilities
As of
July 31, 2026October 31, 2025
In millions
Deferred revenue$1,675 $1,632 
Operating lease liabilities770 815 
Pension, post-retirement, and post-employment liabilities552 564 
Tax liability445 496 
Deferred tax liability18 16 
Other502 513 
$3,962 $4,036 

Interest and Other, Net
Three months ended July 31Nine months ended July 31
202620252026

2025
In millions
Interest expense on borrowings$(96)$(111)$(293)$(329)
Factoring costs(16)(32)(61)(101)
Certain litigation benefits
— 52 — 52 
Non-operating retirement-related credits6 3 28 13 
Other, net12 (4)25 (16)
$(94)$(92)$(301)$(381)
Net Revenue by Region
Three months ended July 31Nine months ended July 31
202620252026

2025
In millions
Americas$6,486 $6,107 $17,921 $17,419 
Europe, Middle East and Africa
5,181 4,502 15,377 13,649 
Asia-Pacific and Japan4,010 3,323 11,225 9,588 
Total net revenue$15,677 $13,932 $44,523 $40,656 
Value of Remaining Performance Obligations
As of July 31, 2026, the estimated value of transaction price allocated to remaining performance obligations was $4.2 billion. HP expects to recognize approximately $2.0 billion of the unearned amount in next 12 months and $2.2 billion thereafter.
HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if:
•the contract has an original expected duration of one year or less; or
•the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or
•the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation.
The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency.
Contract Liabilities
As of July 31, 2026 and October 31, 2025, HP’s contract liabilities balances were $3.4 billion and $3.2 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Condensed Consolidated Balance Sheets.
The increase in the contract liabilities balance for the nine months ended July 31, 2026, was primarily driven by sales of fixed-price support and maintenance services, partially offset by $1.2 billion of revenue recognized that was included in the contract liabilities balance as of October 31, 2025.
Supplier Finance Programs
HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under these programs, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs has no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. For certain programs, HP pays a monthly service fee to a third-party administrator that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of July 31, 2026 and October 31, 2025, HP had $10.9 billion and $8.9 billion respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs. These obligations are included within the Accounts payable line item of HP’s Condensed Consolidated Balance Sheets. As of both July 31, 2026 and October 31, 2025, the Company’s outstanding payment obligations that suppliers elected to sell to participating financial institutions were immaterial and $0.1 billion, respectively.
v3.26.1
Fair Value
9 Months Ended
Jul. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
    The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
As of July 31, 2026As of October 31, 2025
Fair Value Measured UsingFair Value Measured Using
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
In millions
Assets
Cash Equivalents
Government debt(1)
$1,412 $— $— $1,412 $1,878 $— $— $1,878 
Available-for-Sale Investments
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds(2)
11 105 — 116 9 122 — 131 
Derivative Instruments
Foreign currency contracts— 210 — 210 — 182 — 182 
Other derivatives— — — — — 1 — 1 
Total assets$1,423 $318 $— $1,741 $1,887 $308 $— $2,195 
Liabilities
Derivative Instruments
Interest rate contracts$— $— $— $— $— $1 $— $1 
Foreign currency contracts— 167 — 167 — 242 — 242 
Other derivatives— 2 — 2 — 1 — 1 
Total liabilities$— $169 $— $169 $— $244 $— $244 
(1)    Money market funds invested in government debt and traded in active markets are included in Level 1. Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds.
(2)    As of July 31, 2026 and October 31, 2025, $46 million and $63 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
Valuation Techniques
Cash Equivalents and Investments: HP holds money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 7, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Condensed Consolidated Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $8.9 billion as compared to its carrying amount of $9.2 billion as of July 31, 2026. The fair value of HP’s short- and long-term debt was $9.6 billion as compared to its carrying value of $9.7 billion as of October 31, 2025. If measured at fair value in the Condensed Consolidated Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Condensed Consolidated Balance Sheets, the carrying amounts approximate fair value due to their short term maturities. If measured at fair value in the Condensed Consolidated Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Condensed Consolidated Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.
v3.26.1
Financial Instruments
9 Months Ended
Jul. 31, 2026
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash Equivalents and Available-for-Sale Investments
As of July 31, 2026As of October 31, 2025
CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
In millions
Cash Equivalents
Government debt(1)
1,412 — — 1,412 1,878 — — 1,878 
Total cash equivalents1,412 — — 1,412 1,878 — — 1,878 
Available-for-Sale Investments
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds(2)
89 27 — 116 104 27 — 131 
Total available-for-sale investments92 27 — 119 107 27 — 134 
Total cash equivalents and available-for-sale investments$1,504 $27 $— $1,531 $1,985 $27 $— $2,012 
(1)    Money market funds invested in government debt and traded in active markets are included in Level 1. Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds.
(2)    As of July 31, 2026 and October 31, 2025, $46 million and $63 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of July 31, 2026 and October 31, 2025, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
As of July 31, 2026
Amortized CostFair Value
In millions
Due in one year$12 $12 
Due in one to five years35 37 
$47 $49 
Non-marketable equity securities in privately held companies are included in Other non-current assets in the Condensed Consolidated Balance Sheets. These amounted to $142 million and $137 million as of July 31, 2026 and October 31, 2025, respectively.
HP determines credit losses on cash equivalents and available-for-sale debt securities at the individual security level. All instruments are considered investment grade. No credit-related or noncredit-related impairment losses were recorded for the three and nine months ended July 31, 2026.
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Condensed Consolidated Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Condensed Consolidated Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $29 million and $98 million as of July 31, 2026 and as of October 31, 2025, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of July 31, 2026 and October 31, 2025.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Condensed Consolidated Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted products net revenue, cost of products net revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements, contractual pricing and/or business unit specific exposures may extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Condensed Consolidated Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Condensed Consolidated Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
During the three and nine months ended July 31, 2026 and 2025, no portion of the hedging instruments’ gain or loss was excluded from the assessment of effectiveness for fair value and cash flow hedges.
Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets
The gross notional and fair value of derivative instruments in the Condensed Consolidated Balance Sheets were as follows:
As of July 31, 2026As of October 31, 2025
Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
In millions
Derivatives designated as hedging instruments
Fair value hedges:
Interest rate contracts$— $— $— $— $— $250 $— $— $1 $— 
Cash flow hedges:
Foreign currency contracts17,516 163 41 125 17 14,492 141 27 174 54 
Total derivatives designated as hedging instruments17,516 163 41 125 17 14,742 141 27 175 54 
Derivatives not designated as hedging instruments
Foreign currency contracts4,132 6 — 25 — 4,389 14 — 14 — 
Other derivatives166 — — 2 — 168 1 — 1 — 
Total derivatives not designated as hedging instruments4,298 6 — 27 — 4,557 15 — 15 — 
Total derivatives$21,814 $169 $41 $152 $17 $19,299 $156 $27 $190 $54 
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Condensed Consolidated Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of July 31, 2026 and October 31, 2025, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
In the Condensed Consolidated Balance Sheets
(i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
Gross Amount
Recognized
Gross Amount
Offset
Net Amount
Presented
DerivativesFinancial
Collateral
Net Amount
In millions
As of July 31, 2026
Derivative assets$210 $— $210 $133 $162 (1)$(85)
Derivative liabilities$169 $— $169 $133 $328 (2)$(292)
As of October 31, 2025
Derivative assets$183 $— $183 $143 $15 (1)$25 
Derivative liabilities$244 $— $244 $143 $279 (2)$(178)
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any excess or re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.

Effect of Derivative Instruments in the Condensed Consolidated Statements of Earnings
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
Derivative InstrumentHedged ItemLocationYearGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended July 31
Interest rate contractFixed-rate debtInterest and other, net2026$— $— 
2025$2 $(2)
Nine months ended July 31
Interest rate contractFixed-rate debtInterest and other, net2026$1 $(1)
2025$17 $(17)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$141 $59 $(6)$(304)
Interest rate contracts— — — 3 
Total$141 $59 $(6)$(301)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
(Loss)/gain reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Products net revenue$(12)$(184)$(101)$50 
Cost of products net revenue(13)(21)(37)(71)
Operating expenses3 — 7 1 
Interest and other, net4 3 12 9 
Total$(18)$(202)$(119)$(11)
As of July 31, 2026, HP expects to reclassify an estimated accumulated other comprehensive gain of $21 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in Accumulated other comprehensive (loss) income based on the change of market rate, and therefore could have a different impact on earnings.
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Condensed Consolidated Statements of Earnings was as follows:
Gain/(loss) recognized in earnings on derivative instrument
Three months ended July 31Nine months ended July 31
Location2026202520262025
In millions
Foreign currency contractsInterest and other, net$(32)$7 $(39)$(7)
Other derivativesInterest and other, net(11)(3)(3)2 
Total$(43)$4 $(42)$(5)
v3.26.1
Borrowings
9 Months Ended
Jul. 31, 2026
Debt Disclosure [Abstract]  
Borrowings Borrowings
Notes Payable and Short-Term Borrowings
As of July 31, 2026As of October 31, 2025
Amount
Outstanding
Weighted-Average
Interest Rate
Amount
Outstanding
Weighted-Average
Interest Rate
In millions
Current portion of long-term debt$1,292 4.1 %$788 3.2 %
Notes payable to banks and other— — %57 — %
Total notes payable and short-term borrowings
$1,292 $845 

Long-Term Debt
As of
July 31, 2026October 31, 2025
In millions
U.S. Dollar Global Notes(1)
Maturity DateIssue PriceStated Interest Rate
$1,000 issued June 2021
June 202699.808 %1.45 %$— $522 
$1,000 issued June 2020
June 202799.718 %3.00 %1,000 999 
$900 issued June 2022
January 202899.841 %4.75 %900 899 
$1,000 issued March 2022
April 202999.767 %4.00 %999 999 
$500 issued April 2025
April 203099.732 %5.40 %499 499 
$850 issued June 2020
June 203099.790 %3.40 %503 503 
$1,000 issued June 2021
June 203199.573 %2.65 %998 998 
$1,000 issued March 2022
April 203299.966 %4.20 %676 676 
$1,100 issued June 2022
January 203399.725 %5.50 %1,098 1,098 
$500 issued April 2025
April 203599.778 %6.10 %499 499 
$1,200 issued September 2011
September 204199.863 %6.00 %1,199 1,199 
8,371 8,891 
Other borrowings at 1.47%-8.36%, due in fiscal years 2026-2036
826 765 
Fair value adjustment related to hedged debt— (1)
Unamortized debt issuance cost(37)(46)
Current portion of long-term debt(1,292)(788)
Total long-term debt$7,868 $8,821 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
As disclosed in Note 7, “Financial Instruments,” HP uses interest rate swaps to mitigate some of the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates. Interest rates shown in the table of long-term debt have not been adjusted to reflect the impact of any interest rate swaps.
Commercial Paper
As of July 31, 2026, HP maintained a U.S. commercial paper program for the issuance of U.S. dollar-denominated commercial paper. The principal amount outstanding under this program and certain short-term borrowings at any time cannot exceed a $6.0 billion authorization by HP’s Board of Directors. As of July 31, 2026 and October 31, 2025, no commercial paper was outstanding under the program.
Credit Facility
As of July 31, 2026, HP maintained a $5.0 billion 5-year sustainability-linked senior unsecured committed revolving credit facility, which HP entered into on August 1, 2024. Commitments under the revolving credit facility will be available until August 1, 2029. Commitment fees, interest rates and other terms of borrowing under the revolving credit facility vary based on HP’s external credit ratings and certain sustainability metrics. Funds borrowed under the revolving credit facility may be used for general corporate purposes.
As of July 31, 2026, there were no borrowings outstanding under the revolving credit facility. The revolving credit facility also acts as a backstop to provide liquidity support for our commercial paper program. As of July 31, 2026, HP was in compliance with the covenants in the credit agreement governing the revolving credit facility.
Available Borrowing Resources
As of July 31, 2026, HP had available borrowing resources of $0.9 billion from uncommitted lines of credit in addition to funds available under the revolving credit facility.
v3.26.1
Stockholders' Deficit
9 Months Ended
Jul. 31, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Deficit Stockholders’ Deficit
Share Repurchase Program
HP’s share repurchase program authorizes both open market and private repurchase transactions. During the three and nine months ended July 31, 2026, HP executed share repurchases of 12.2 million and 30.5 million shares and settled total shares for $0.3 billion and $0.7 billion, respectively. During the three and nine months ended July 31, 2025, HP executed share repurchases of 5.5 million and 11.4 million shares and settled total shares for $0.2 billion and $0.4 billion, respectively. Share repurchases executed during the three months and nine months ended July 31, 2025 included 0.3 million shares settled in August 2025.
The shares repurchased during the nine months ended July 31, 2026 and 2025 were all open market repurchase transactions. As of July 31, 2026, HP had approximately $7.7 billion remaining under the share repurchase authorization approved by HP’s Board of Directors.
Changes and reclassifications related to Accumulated Other Comprehensive Loss, net of taxes
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Other comprehensive income (loss), net of taxes:
Unrealized components of available-for-sale debt securities
Balance at the beginning of period$30 $20 $29 $14 
Unrealized gains arising during the period1 5 2 11 
Tax effects on change in unrealized components of available-for-sale securities— (1)— (1)
Unrealized components of available-for-sale debt securities, net of taxes1 4 2 10 
Balance at the end of period$31 $24 $31 $24 
Unrealized components of cash flow hedges
Balance at the beginning of period$(81)$(393)$(48)$47 
Unrealized gains (losses) arising during the period141 59 (6)(301)
Losses reclassified into earnings18 202 119 11 
Tax effects on change in unrealized components of cash flow hedges(28)(61)(15)50 
Unrealized components of cash flow hedges, net of taxes131 200 98 (240)
Balance at the end of period$50 $(193)$50 $(193)
Unrealized components of defined benefit plans
Balance at the beginning of period$(476)$(488)$(450)$(496)
Unrealized gains (losses) arising during the period20 (7)(14)(8)
Amortization of actuarial loss and prior service benefit
5 5 14 15 
Curtailments, settlements and other3 2 5 2 
Tax effects on change in unrealized components of defined benefit plans(4)— (7)(1)
Unrealized components of defined benefit plans, net of taxes24 — (2)8 
Balance at the end of period$(452)$(488)$(452)$(488)
Cumulative translation adjustment
Balance at the beginning of period$26 $18 $12 $1 
Change in cumulative translation adjustment(3)(1)11 16 
Tax effect on change in cumulative translation adjustment— (1)— (1)
Cumulative translation adjustment, net of taxes(3)(2)11 15 
Balance at the end of period$23 $16 $23 $16 
Other comprehensive income (loss)$153 $202 $109 $(207)
Accumulated other comprehensive loss$(348)$(641)$(348)$(641)
v3.26.1
Earnings Per Share
9 Months Ended
Jul. 31, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
Three months ended July 31Nine months ended July 31
2026202520262025
In millions, except per share amounts
Numerator:
Net earnings$661 $763 $1,656 $1,734 
Denominator:
Weighted-average shares used to compute basic net EPS919 947 922 948 
Dilutive effect of employee stock plans8 7 5 7 
Weighted-average shares used to compute diluted net EPS927 954 927 955 
Net earnings per share:
Basic$0.72 $0.81 $1.80 $1.83 
Diluted$0.71 $0.80 $1.79 $1.82 
Anti-dilutive weighted-average stock plans(1)
12 14 17 8 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent average unrecognized compensation cost.
v3.26.1
Litigation and Contingencies
9 Months Ended
Jul. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Litigation and Contingencies Litigation and Contingencies
HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of July 31, 2026, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Litigation, Proceedings and Investigations
Copyright Levies. Proceedings are ongoing or have been concluded involving HP in certain European countries, challenging the imposition or the modification of levies regimes upon IT equipment (such as PCs or printers) or the restrictions to exonerate the application of private copying levies on devices purchased by business users. The levies are generally based upon the number of products sold and the per-product amounts of the levies, which vary. Some European countries are expected to implement legislation to introduce or extend existing levy schemes to digital devices. HP, other companies and various industry associations have opposed the extension of levies to the digital product and certain requirements for business sales exemptions and have advocated alternative models of compensation to rights holders.
Based on the exemption of levies on business sales and industry opposition to increasing levies to digital products, HP’s assessments of the merits of various proceedings and HP’s estimates of the number of units impacted and the amounts of the levies, HP has accrued amounts that it believes are adequate to address the ongoing disputes.
India Directorate of Revenue Intelligence Proceedings. On April 30 and May 10, 2010, the India Directorate of Revenue Intelligence (the “DRI”) issued notices to Hewlett-Packard India Sales Private Limited (“HP India”), a subsidiary of HP, seven HP India employees and one former HP India employee alleging that HP India underpaid customs duties while importing products and spare parts into India and seeking to recover an aggregate of approximately $370 million, plus penalties and interest. On April 11, 2012, the Bangalore Commissioner of Customs issued an order on the products-related notice affirming certain duties and penalties against HP India and the named individuals of approximately $386 million (plus interest). On April 20, 2012, the Commissioner issued an order on the parts-related notice affirming duties and penalties against HP India and certain of the named individuals of approximately $17 million. HP India filed appeals of the Commissioner’s orders before the Customs, Excise and Service Tax Appellate Tribunal (the “Customs Tribunal”). The Customs Department also filed cross-appeals before the Customs Tribunal. On October 27, 2014, the Customs Tribunal commenced hearings on the cross-appeals of the Commissioner’s orders and rejected HP India’s request to remand the matter to the Commissioner on procedural grounds. The Customs Tribunal began hearing the parties’ cross appeals on April 10, 2025, and completed the hearing in December 2025. On May 6, 2026, the Customs Tribunal announced that a decision has been adopted, but the content of the decision was not made available to the parties at that time. On June 29, 2026, the Customs Tribunal issued its decision. The Tribunal overturned several duty, interest, penalty and confiscation findings, and eliminated all individual penalties. The revised duty, interest and penalty amounts will be determined through a damage ruling by the Customs Authority. That ruling is expected no earlier than September 2026 and could be issued significantly later. HP intends to appeal the 2026 orders before the Supreme Court of India by August 28, 2026. DRI also is entitled to appeal. Pursuant to the separation and distribution agreement, Hewlett Packard Enterprise has agreed to indemnify HP in part, based on the extent to which any liability arises from the products and spare parts of Hewlett Packard Enterprise’s businesses.
Media Content Protection LLC Patent Litigation (formerly Philips Patent Litigation). In September 2020, Koninklijke Philips N.V. and Philips North America LLC (collectively, “Philips”) filed a complaint against HP for patent infringement in federal court for the District of Delaware and filed a companion complaint with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP and 8 other sets of respondents. Both complaints allege that certain digital video-capable devices and components thereof infringe four of Philips’ patents. In October 2020, the ITC instituted an investigation, and Philips later withdrew two of the four patents. On March 23, 2022, the ITC rendered a final determination that no violation of Section 337 has occurred. Philips did not appeal and elected to resume litigation with its case in federal court. Philips seeks unspecified damages and an injunction against HP, and the prior stay has been lifted. On August 10, 2023, HP filed a motion for summary judgment of indefiniteness for all asserted claims. On July 1, 2024, the district court denied the motion without prejudice to renew. Philips conveyed the patents asserted in the district court action to Media Content Protection LLC (“MCP”), and MCP was substituted as plaintiff in place of Philips. As of November 25, 2025, the district court has ruled that all patents asserted against HP are invalid under 35 U.S.C. § 101, subject to appeal.
In re HP Inc. Derivative Litigation. On May 17, 2021, stockholder Scott Franklin filed a derivative complaint against certain then-current and former officers and directors in federal court in the District of Delaware. Plaintiff purports to bring the action on behalf of HP, which he has named as a nominal defendant, bringing claims for breach of fiduciary duty and violations of securities laws. The derivative plaintiff seeks compensatory damages, governance reforms, and other relief. By court order following stipulations by the parties, the case was transferred to the Northern District of California, and the case was stayed pending a ruling on the motion to dismiss in York County on behalf of the County of York Retirement Fund v. HP Inc., et al. (“York County”), and exhaustion of all related appeals. On January 13, 2022, stockholder Gerald Lovoi filed a derivative complaint in federal court in the Northern District of California against the same current and former officers and directors named in the Franklin action. The complaint alleges the same basic claims based on the same alleged conduct as the Franklin action and seeks similar relief. By stipulation of the parties, the Lovoi action was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. On May 31, 2024, the court adopted a stipulation in which the derivative plaintiffs and defendants agreed to consolidate the derivative proceedings, close the Lovoi action, and extend the current stay through summary judgment in the York County action. On April 24, 2026, the derivative plaintiffs filed an unopposed motion for preliminary approval of the settlement set forth in the stipulation and agreement of settlement dated April 22, 2026, which resolves all derivative claims in the consolidated derivative action. The district court preliminarily approved the settlement on May 29, 2026, and the final settlement hearing is scheduled for September 2026.
Legal Proceedings re Authentication of Supplies. Since 2016, HP has from time to time been named in civil litigation, or been the subject of government investigations, involving supplies authentication protocols used in certain HP printers in multiple geographies, including but not limited to the United States, Italy, Israel, the Netherlands, Australia and New Zealand. The supplies authentication protocols are often referred to as Dynamic Security. The core allegations in these proceedings claim misleading or inadequate consumer notifications and permissions pertaining to the use of Dynamic Security, the installation of firmware updates, or the potential inability of cartridges with clone chips or circuitry to work in HP printers with Dynamic Security. Plaintiffs base or have based their claims on various legal theories, including but not limited to unfair competition, computer trespass, and similar statutory claims. Among other relief, Plaintiffs have sought or seek money damages and in certain cases have or may seek injunctive relief against the use or operation of Dynamic Security or relief requiring interoperability. If HP is not successful in its defense of these cases or investigations, it could be subject to damages, penalties, significant settlement demands, or injunctive relief that may be costly or may disrupt operations. Certain of these proceedings in the United States, Italy, the Netherlands, Israel, Australia and New Zealand have been resolved, have concluded, or have concluded subject only to HP’s pending appeal. Digital Revolution B.V. (trading as 123Inkt) filed civil litigation, including competition claims, against HP Nederlands B.V., et al. (Netherlands) in March 2020. HP substantially prevailed before the trial court, and both parties appealed. On November 19, 2024, the court of appeal issued a decision rejecting competition claims against HP and providing that use of Dynamic Security by HP is not unlawful. On February 18, 2025, Digital Revolution filed a cassation appeal against the decision before the Dutch Supreme Court. On December 12, 2025 the Attorney General issued his non-binding opinion advising the Supreme Court to reject the appeal. The Dutch Supreme Court issued its decision on June 5, 2026, rejecting competition claims against HP and providing that use of Dynamic Security by HP is not unlawful. In addition, a putative class action was filed against HP in federal court in Illinois in January 2024, arising out of the use of Dynamic Security firmware updates in HP printers. Plaintiffs seek compensatory damages, restitution, injunctive relief against alleged unfair and anticompetitive business practices, and other relief. On September 30, 2025, the court dismissed the complaint in its entirety but gave plaintiffs leave to file an amended complaint. Plaintiffs filed an amended complaint. The court has set a hearing in August 2026 to address HP’s motion to dismiss the amended complaint. The case is in its early stages.
Autonomy-Related Legal Proceedings. In 2015, four former Hewlett Packard Company subsidiaries that became subsidiaries of Hewlett Packard Enterprise at the time of the Separation (Autonomy Corporation Limited, Hewlett Packard Vision BV, Autonomy Systems Limited, and Autonomy, Inc., hereinafter the “Claimants”) initiated civil proceedings in the U.K. High Court of Justice against two members of Autonomy’s former management, Michael Lynch and Sushovan Hussain, for breach of their fiduciary duties in causing Autonomy group companies to engage in improper transactions and accounting practices before and in connection with the 2011 acquisition of Autonomy. Trial concluded in January 2020. In May 2022, the court issued its liability judgment, finding that the Claimants had succeeded on substantially all claims and that Messrs. Lynch and Hussain engaged in fraud, and dismissing a counterclaim filed by Mr. Lynch. The court deferred the issue of damages to further proceedings, but indicated that damages awarded may be substantially less than was claimed. In February 2024, the court held a two-week trial on damages, the Claimants sought recovery for $4 billion in losses, and the court took the issue under advisement. In May 2025, Claimants reached an agreement with Mr. Hussain to resolve claims against him. On July 22, 2025, the court issued its ruling on the quantum of damages, finding that the Lynch estate owed approximately 740 million pounds. The court held a hearing for the week of November 17, 2025, to address additional matters, including attorneys’ fees, pre-judgment interest, and the relevant date to use for the exchange rate to convert the recovery from pounds to dollars. On March 24, 2026, the court entered its judgment, awarding damages plus interest totaling $1.24 billion, and denying the Lynch estate’s request for permission to appeal. The damages award includes a set-off for prior settlements. The Lynch estate filed a request for permission to appeal with the appellate level court. The Claimants have opposed that request. On August 25, 2026, the Court of Appeal denied the Lynch Estate's request for permission to appeal most issues raised by the Estate. The appeal may proceed on a limited number of issues relating primarily to damages. Litigation is unpredictable, and there can be no assurance of a recovery. Any amount ultimately recovered would be recorded in the period received. No adjustment has been recorded in the financial statements in relation to this potential recovery. Pursuant to the terms of the separation and distribution agreement, HP and Hewlett Packard Enterprise will share equally in any recovery.
Standard Essential Patent matters. HP is engaged in a number of patent-related matters involving patents asserted to be essential to industry standards (such as Wi Fi). This includes discussions with third parties regarding patent license arrangements and, in some instances, litigation. Based on HP’s assessment of various matters, HP has accrued amounts for those matters for which a loss is probable and reasonably estimable.
Environmental
HP is, and may become a party to, proceedings brought by U.S., state, or other governmental entities or private third parties under federal, state, local, or foreign environmental laws, including the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), known as “Superfund,” or state laws similar to CERCLA. HP is also conducting environmental investigations or remediation at several current or former operating sites and former disposal sites pursuant to administrative orders or consent agreements with environmental agencies.
Tariffs
On February 20, 2026, the U.S. Supreme Court held that tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) were not authorized by statute which removed the obligation for and collection of related tariffs. As of July 31, 2026, the Company has applied for the recovery of approximately $0.3 billion of previously paid IEEPA tariffs. The Company received $127 million of refunds during the three and nine months ended July 31, 2026, and $91 million subsequent to the reporting period. Refunds are recognized as a reduction of Products cost of net revenue when received.
v3.26.1
Guarantees, Indemnifications and Warranties
9 Months Ended
Jul. 31, 2026
Guarantees [Abstract]  
Guarantees, Indemnifications and Warranties Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 11, “Litigation and Contingencies”.
Indemnifications 
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
HP’s aggregate product warranty liabilities and changes were as follows:
Nine months ended July 31, 2026
In millions
Balance at beginning of period$452 
Accruals and adjustments468 
Settlements made
(521)
Balance at end of period$399 
v3.26.1
Commitments
9 Months Ended
Jul. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments Commitments
Unconditional Purchase Obligations
HP’s unconditional purchase obligations include agreements to purchase goods or services that are enforceable and legally binding on HP and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum or variable price and volume provisions and the approximate timing of the transaction. Unconditional purchase obligations exclude agreements that are cancellable without penalty. The Company's purchase obligations under variable price provisions approximate market prices at the time of purchase and are estimated using current period pricing. Actual future variable price purchase commitments may significantly vary depending on market prices and product mix at the time of purchase. The Company's unconditional purchase obligations are primarily related to inventory and service support.
As of July 31, 2026, unconditional purchase obligations were as follows:
Fiscal yearIn millions
2026(1)
$143 
2027619 
2028997 
2029271 
2030104 
Thereafter3 
Total$2,137 
(1)    Represents expected unconditional purchase obligations for the remaining three months of fiscal year 2026.
The Company's purchase obligations increased from $1.1 billion as of October 31, 2025 due to inventory purchase obligations of processors under variable price provisions to support future business needs.
v3.26.1
Insider Trading Arrangements
3 Months Ended
Jul. 31, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Anneliese Olson [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On June 4, 2026, Anneliese Olson, our President of Imaging, Printing & Solutions, adopted a written plan for the sale of up to 170,929 shares of our common stock underlying time-based restricted stock units and shares of our common stock underlying any dividend equivalent units that accrue with respect to such awards. The plan is scheduled to commence on October 29, 2026 and is scheduled to expire on March 31, 2027, or on any earlier date on which all of the shares have been sold. This plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Name Anneliese Olson
Title President of Imaging, Printing & Solutions
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 4, 2026
Expiration Date March 31, 2027
Arrangement Duration 153 days
Aggregate Available 170,929
v3.26.1
Basis of Presentation (Policies)
9 Months Ended
Jul. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying Condensed Consolidated Financial Statements of HP and its wholly owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2025 in HP’s Annual Report on Form 10-K, filed on December 13, 2025. The Condensed Consolidated Balance Sheet for October 31, 2025 was derived from audited financial statements.
Principles of Consolidation
Principles of Consolidation
The Condensed Consolidated Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Reclassifications
Reclassifications
HP has reclassified certain prior-year amounts to conform to the current-year presentation.
Use of Estimates
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Issued Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued guidance that requires disaggregation of specific expense categories in disclosures within the footnotes to the financial statements on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2028 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. The Company will adopt the guidance prospectively. Adoption of this new guidance will result in additional disclosures in the “Taxes on Earnings” note in the Company’s Consolidated Financial Statements but will not impact the consolidated financial results.
Segment Information
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges, amortization of intangible assets, and certain litigation (charges) benefits, net.
Taxes on Earnings HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Condensed Consolidated Statements of Earnings.
Supplementary Financial Information
HP utilizes certain third-party arrangements in the normal course of business as part of HP’s cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Condensed Consolidated Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Condensed Consolidated Balance Sheets. The recourse obligations as of July 31, 2026 and October 31, 2025 were not material.
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
Valuation Techniques
Cash Equivalents and Investments: HP holds money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 7, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Condensed Consolidated Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $8.9 billion as compared to its carrying amount of $9.2 billion as of July 31, 2026. The fair value of HP’s short- and long-term debt was $9.6 billion as compared to its carrying value of $9.7 billion as of October 31, 2025. If measured at fair value in the Condensed Consolidated Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Condensed Consolidated Balance Sheets, the carrying amounts approximate fair value due to their short term maturities. If measured at fair value in the Condensed Consolidated Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Condensed Consolidated Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.
Cash Equivalents and Available-for-Sale Investments All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents.
Non-Marketable Equity Securities Investments Non-marketable equity securities in privately held companies are included in Other non-current assets in the Condensed Consolidated Balance Sheets.
Derivative Instruments
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Condensed Consolidated Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Condensed Consolidated Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $29 million and $98 million as of July 31, 2026 and as of October 31, 2025, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of July 31, 2026 and October 31, 2025.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Condensed Consolidated Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted products net revenue, cost of products net revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements, contractual pricing and/or business unit specific exposures may extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Condensed Consolidated Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Condensed Consolidated Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
Offsetting of Derivatives Instruments
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Condensed Consolidated Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements.
Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
Litigation and Contingencies July 31, 2026, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 11, “Litigation and Contingencies”.
Indemnifications 
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
v3.26.1
Segment Information (Tables)
9 Months Ended
Jul. 31, 2026
Segment Reporting [Abstract]  
Schedule of Reconciliation of Revenue from Segment Operating Results to HP Consolidated Results
Significant Segment Expenses and Operating Results
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Net revenue
Commercial PS$8,579 $7,036 $23,575 $20,467 
Consumer PS3,188 2,895 8,656 7,712 
Personal Systems11,767 9,931 32,231 28,179 
Supplies2,536 2,609 8,089 8,166 
Commercial Printing1,101 1,113 3,374 3,424 
Consumer Printing275 280 831 889 
Printing3,912 4,002 12,294 12,479 
Corporate Investments— — — — 
Total segment net revenue15,679 13,933 44,525 40,658 
Other(2)(1)(2)(2)
Total net revenue$15,677 $13,932 $44,523 $40,656 
Cost of net revenue
Personal Systems$10,250 $8,421 $27,785 $24,009 
Printing2,475 2,640 7,889 8,134 
Corporate Investments— — 1 2 
Total segment cost of net revenue12,725 11,061 35,675 32,145 
Operating expenses
Personal Systems$980 $969 $2,868 $2,713 
Printing728 681 2,164 2,059 
Corporate Investments28 24 80 67 
Total segment operating expenses1,736 1,674 5,112 4,839 
Earnings before taxes
Personal Systems$537 $541 $1,578 $1,457 
Printing709 681 2,241 2,286 
Corporate Investments(28)(24)(81)(69)
Total segment earnings from operations1,218 1,198 3,738 3,674 
Corporate and unallocated costs and other(102)(103)(258)(302)
Stock-based compensation expense(95)(100)(389)(432)
Restructuring and other charges(48)(110)(539)(302)
Acquisition and divestiture charges(4)(8)(6)(31)
Amortization of intangible assets(75)(159)(220)(287)
Certain litigation charges
(2)(2)(63)(105)
Interest and other, net(1)
(94)(92)(301)(381)
Total earnings before taxes$798 $624 $1,962 $1,834 
(1)    The three and nine months ended July 31, 2025 includes Certain litigation benefits from a single litigation matter that does not relate to HP's ongoing business operations.
Schedule of Reconciliation of Operating Profit (Loss) from Segment Operating Results to HP Consolidated Results
Significant Segment Expenses and Operating Results
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Net revenue
Commercial PS$8,579 $7,036 $23,575 $20,467 
Consumer PS3,188 2,895 8,656 7,712 
Personal Systems11,767 9,931 32,231 28,179 
Supplies2,536 2,609 8,089 8,166 
Commercial Printing1,101 1,113 3,374 3,424 
Consumer Printing275 280 831 889 
Printing3,912 4,002 12,294 12,479 
Corporate Investments— — — — 
Total segment net revenue15,679 13,933 44,525 40,658 
Other(2)(1)(2)(2)
Total net revenue$15,677 $13,932 $44,523 $40,656 
Cost of net revenue
Personal Systems$10,250 $8,421 $27,785 $24,009 
Printing2,475 2,640 7,889 8,134 
Corporate Investments— — 1 2 
Total segment cost of net revenue12,725 11,061 35,675 32,145 
Operating expenses
Personal Systems$980 $969 $2,868 $2,713 
Printing728 681 2,164 2,059 
Corporate Investments28 24 80 67 
Total segment operating expenses1,736 1,674 5,112 4,839 
Earnings before taxes
Personal Systems$537 $541 $1,578 $1,457 
Printing709 681 2,241 2,286 
Corporate Investments(28)(24)(81)(69)
Total segment earnings from operations1,218 1,198 3,738 3,674 
Corporate and unallocated costs and other(102)(103)(258)(302)
Stock-based compensation expense(95)(100)(389)(432)
Restructuring and other charges(48)(110)(539)(302)
Acquisition and divestiture charges(4)(8)(6)(31)
Amortization of intangible assets(75)(159)(220)(287)
Certain litigation charges
(2)(2)(63)(105)
Interest and other, net(1)
(94)(92)(301)(381)
Total earnings before taxes$798 $624 $1,962 $1,834 
(1)    The three and nine months ended July 31, 2025 includes Certain litigation benefits from a single litigation matter that does not relate to HP's ongoing business operations.
v3.26.1
Restructuring and Other Charges (Tables)
9 Months Ended
Jul. 31, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Other Charges
HP’s restructuring and other charges under the Fiscal 2026 Plan and Fiscal 2023 Plan were as follows:

Fiscal 2026 Plan
Three months ended July 31, 2026Nine months ended July 31, 2026
Severance$38 $200 
Non-labor7 30 
Special Termination Benefit— 280 
Other charges(1)
15 37 
$60 $547 
Other prior plan costs(2)
(12)(8)
$48 $539 

Fiscal 2023 Plan
Three months ended July 31, 2025Nine months ended July 31, 2025
Severance$77 $218 
Non-labor14 34 
Other charges(1)
19 50 
$110 $302 

(1)     Other charges are distinct from ongoing operational costs and primarily include third-party professional services and other non-recurring costs, which include artificial intelligence adoption and enablement costs under the Fiscal 2026 Plan. Effective second quarter of fiscal 2026, other charges also includes CEO transition costs, which comprises of executive hiring and retention costs.
(2)    Other prior plans primarily include the Fiscal 2023 Plan, which is substantially complete. HP does not expect any further material activity associated with this plan.
Schedule of Restructuring Activities by Plan
The reconciliation of the beginning and ending liability balance showing activity during the year is as follows:
Fiscal 2026 Plan
Severance Non-laborOther prior-year plansTotal
In millions
Accrued balance as of October 31, 2025$— $— $172 $172 
Charges200 30 (8)222 
Cash payments(91)(13)(122)(226)
Non-cash and other adjustments— (17)2 (15)
Accrued balance as of July 31, 2026$109 $— $44 $153 
Reflected in the Condensed Consolidated Balance Sheets
Other current liabilities$76 $— $41 $117 
Other non-current liabilities$33 $— $3 $36 
Accrued balance as of October 31, 2024$— $— $138 $138 
Charges— — 252 252 
Cash payments— — (188)(188)
Non-cash and other adjustments— — (21)(21)
Accrued balance as of July 31, 2025$— $— $181 $181 
v3.26.1
Supplementary Financial Information (Tables)
9 Months Ended
Jul. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents and Restricted Cash
As of
July 31, 2026October 31, 2025
In millions
Cash and cash equivalents$4,169 $3,690 
Restricted cash(1)
— 15 
$4,169 $3,705 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Schedule of Restricted Cash
Cash, Cash Equivalents and Restricted Cash
As of
July 31, 2026October 31, 2025
In millions
Cash and cash equivalents$4,169 $3,690 
Restricted cash(1)
— 15 
$4,169 $3,705 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes
The allowance for credit losses related to accounts receivable and changes were as follows:
Nine months ended July 31, 2026
In millions
Balance at beginning of period$83 
Current-period allowance for credit losses(18)
Deductions, net of recoveries(8)
Balance at end of period$57 
Schedule of Trade Receivables Sold and Cash Received
The following is a summary of the activity under these arrangements:
Three months ended July 31Nine months ended July 31
202620252026

2025
In millions
Balance at beginning of period(1)
$289 $217 $117 $284 
Trade receivables sold1,729 3,085 7,153 9,259 
Cash receipts(2,009)(3,184)(7,264)(9,431)
Foreign currency and other(5)2 (2)8 
Balance at end of period(1)
$4 $120 $4 $120 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Condensed Consolidated Balance Sheets.
Schedule of Inventory
Inventory
As of
July 31, 2026October 31, 2025
In millions
Finished goods$5,958 $4,721 
Purchased parts and fabricated assemblies4,364 3,791 
$10,322 $8,512 
Schedule of Other Current Assets
Other Current Assets
As of
July 31, 2026October 31, 2025
In millions
Supplier and other receivables
$2,468 $1,981 
Prepaid and other current assets
1,486 1,577 
Value-added taxes receivable1,133 986 
$5,087 $4,544 
Schedule of Property, Plant and Equipment, Net
Property, Plant and Equipment, Net
As of
July 31, 2026October 31, 2025
In millions
Land, buildings and leasehold improvements$2,634 $2,619 
Machinery and equipment, including equipment held for lease6,251 5,867 
8,885 8,486 
Accumulated depreciation(5,775)(5,437)
$3,110 $3,049 
Schedule of Other Non-Current Assets
Other Non-Current Assets
As of
July 31, 2026October 31, 2025
In millions
Deferred tax assets$3,413 $3,318 
Right-of-use assets1,086 1,129 
Intangible assets(1)
802 1,012 
Prepaid pension and post-retirement benefit assets(2)
220 425 
Deposits and prepaid187 316 
Other1,411 1,361 
$7,119 $7,561 
(1)    During the three and nine months ended July 31, 2026, the Company incurred impairment charges of $23 million and $55 million related to acquired customer contracts, customer lists and distribution agreements and technology and patents related to the Personal Systems segment.
(2)    Decrease relates to the reclassification of EER benefits to be paid from the U.S. defined pension plan in connection with the Fiscal 2026 Plan. See Note 3 “Restructuring and Other Charges” for further information.
Schedule of Other Current Liabilities
Other Current Liabilities
As of
July 31, 2026October 31, 2025
In millions
Sales and marketing programs$3,476 $3,103 
Deferred revenue1,761 1,609 
Other accrued taxes1,410 1,258 
Employee compensation and benefits1,272 965 
Operating lease liabilities409 401 
Warranty354 401 
Tax liability101 297 
Other2,505 2,328 
$11,288 $10,362 
Schedule of Other Non-Current Liabilities
Other Non-Current Liabilities
As of
July 31, 2026October 31, 2025
In millions
Deferred revenue$1,675 $1,632 
Operating lease liabilities770 815 
Pension, post-retirement, and post-employment liabilities552 564 
Tax liability445 496 
Deferred tax liability18 16 
Other502 513 
$3,962 $4,036 
Schedule of Interest and Other, Net
Interest and Other, Net
Three months ended July 31Nine months ended July 31
202620252026

2025
In millions
Interest expense on borrowings$(96)$(111)$(293)$(329)
Factoring costs(16)(32)(61)(101)
Certain litigation benefits
— 52 — 52 
Non-operating retirement-related credits6 3 28 13 
Other, net12 (4)25 (16)
$(94)$(92)$(301)$(381)
Schedule of Net Revenue by Region
Net Revenue by Region
Three months ended July 31Nine months ended July 31
202620252026

2025
In millions
Americas$6,486 $6,107 $17,921 $17,419 
Europe, Middle East and Africa
5,181 4,502 15,377 13,649 
Asia-Pacific and Japan4,010 3,323 11,225 9,588 
Total net revenue$15,677 $13,932 $44,523 $40,656 
v3.26.1
Fair Value (Tables)
9 Months Ended
Jul. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
As of July 31, 2026As of October 31, 2025
Fair Value Measured UsingFair Value Measured Using
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
In millions
Assets
Cash Equivalents
Government debt(1)
$1,412 $— $— $1,412 $1,878 $— $— $1,878 
Available-for-Sale Investments
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds(2)
11 105 — 116 9 122 — 131 
Derivative Instruments
Foreign currency contracts— 210 — 210 — 182 — 182 
Other derivatives— — — — — 1 — 1 
Total assets$1,423 $318 $— $1,741 $1,887 $308 $— $2,195 
Liabilities
Derivative Instruments
Interest rate contracts$— $— $— $— $— $1 $— $1 
Foreign currency contracts— 167 — 167 — 242 — 242 
Other derivatives— 2 — 2 — 1 — 1 
Total liabilities$— $169 $— $169 $— $244 $— $244 
(1)    Money market funds invested in government debt and traded in active markets are included in Level 1. Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds.
(2)    As of July 31, 2026 and October 31, 2025, $46 million and $63 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
v3.26.1
Financial Instruments (Tables)
9 Months Ended
Jul. 31, 2026
Investments, All Other Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Investments
Cash Equivalents and Available-for-Sale Investments
As of July 31, 2026As of October 31, 2025
CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
In millions
Cash Equivalents
Government debt(1)
1,412 — — 1,412 1,878 — — 1,878 
Total cash equivalents1,412 — — 1,412 1,878 — — 1,878 
Available-for-Sale Investments
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds(2)
89 27 — 116 104 27 — 131 
Total available-for-sale investments92 27 — 119 107 27 — 134 
Total cash equivalents and available-for-sale investments$1,504 $27 $— $1,531 $1,985 $27 $— $2,012 
(1)    Money market funds invested in government debt and traded in active markets are included in Level 1. Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds.
(2)    As of July 31, 2026 and October 31, 2025, $46 million and $63 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities
Contractual maturities of investments in available-for-sale debt securities were as follows:
As of July 31, 2026
Amortized CostFair Value
In millions
Due in one year$12 $12 
Due in one to five years35 37 
$47 $49 
Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Condensed Consolidated Balance Sheets were as follows:
As of July 31, 2026As of October 31, 2025
Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
In millions
Derivatives designated as hedging instruments
Fair value hedges:
Interest rate contracts$— $— $— $— $— $250 $— $— $1 $— 
Cash flow hedges:
Foreign currency contracts17,516 163 41 125 17 14,492 141 27 174 54 
Total derivatives designated as hedging instruments17,516 163 41 125 17 14,742 141 27 175 54 
Derivatives not designated as hedging instruments
Foreign currency contracts4,132 6 — 25 — 4,389 14 — 14 — 
Other derivatives166 — — 2 — 168 1 — 1 — 
Total derivatives not designated as hedging instruments4,298 6 — 27 — 4,557 15 — 15 — 
Total derivatives$21,814 $169 $41 $152 $17 $19,299 $156 $27 $190 $54 
Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Assets As of July 31, 2026 and October 31, 2025, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
In the Condensed Consolidated Balance Sheets
(i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
Gross Amount
Recognized
Gross Amount
Offset
Net Amount
Presented
DerivativesFinancial
Collateral
Net Amount
In millions
As of July 31, 2026
Derivative assets$210 $— $210 $133 $162 (1)$(85)
Derivative liabilities$169 $— $169 $133 $328 (2)$(292)
As of October 31, 2025
Derivative assets$183 $— $183 $143 $15 (1)$25 
Derivative liabilities$244 $— $244 $143 $279 (2)$(178)
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any excess or re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Liabilities As of July 31, 2026 and October 31, 2025, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
In the Condensed Consolidated Balance Sheets
(i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
Gross Amount
Recognized
Gross Amount
Offset
Net Amount
Presented
DerivativesFinancial
Collateral
Net Amount
In millions
As of July 31, 2026
Derivative assets$210 $— $210 $133 $162 (1)$(85)
Derivative liabilities$169 $— $169 $133 $328 (2)$(292)
As of October 31, 2025
Derivative assets$183 $— $183 $143 $15 (1)$25 
Derivative liabilities$244 $— $244 $143 $279 (2)$(178)
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any excess or re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
Derivative InstrumentHedged ItemLocationYearGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended July 31
Interest rate contractFixed-rate debtInterest and other, net2026$— $— 
2025$2 $(2)
Nine months ended July 31
Interest rate contractFixed-rate debtInterest and other, net2026$1 $(1)
2025$17 $(17)
Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$141 $59 $(6)$(304)
Interest rate contracts— — — 3 
Total$141 $59 $(6)$(301)
Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
(Loss)/gain reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Products net revenue$(12)$(184)$(101)$50 
Cost of products net revenue(13)(21)(37)(71)
Operating expenses3 — 7 1 
Interest and other, net4 3 12 9 
Total$(18)$(202)$(119)$(11)
Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Condensed Consolidated Statements of Earnings was as follows:
Gain/(loss) recognized in earnings on derivative instrument
Three months ended July 31Nine months ended July 31
Location2026202520262025
In millions
Foreign currency contractsInterest and other, net$(32)$7 $(39)$(7)
Other derivativesInterest and other, net(11)(3)(3)2 
Total$(43)$4 $(42)$(5)
v3.26.1
Borrowings (Tables)
9 Months Ended
Jul. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Notes Payable and Short-Term Borrowings
Notes Payable and Short-Term Borrowings
As of July 31, 2026As of October 31, 2025
Amount
Outstanding
Weighted-Average
Interest Rate
Amount
Outstanding
Weighted-Average
Interest Rate
In millions
Current portion of long-term debt$1,292 4.1 %$788 3.2 %
Notes payable to banks and other— — %57 — %
Total notes payable and short-term borrowings
$1,292 $845 
Schedule of Long-Term Debt
Long-Term Debt
As of
July 31, 2026October 31, 2025
In millions
U.S. Dollar Global Notes(1)
Maturity DateIssue PriceStated Interest Rate
$1,000 issued June 2021
June 202699.808 %1.45 %$— $522 
$1,000 issued June 2020
June 202799.718 %3.00 %1,000 999 
$900 issued June 2022
January 202899.841 %4.75 %900 899 
$1,000 issued March 2022
April 202999.767 %4.00 %999 999 
$500 issued April 2025
April 203099.732 %5.40 %499 499 
$850 issued June 2020
June 203099.790 %3.40 %503 503 
$1,000 issued June 2021
June 203199.573 %2.65 %998 998 
$1,000 issued March 2022
April 203299.966 %4.20 %676 676 
$1,100 issued June 2022
January 203399.725 %5.50 %1,098 1,098 
$500 issued April 2025
April 203599.778 %6.10 %499 499 
$1,200 issued September 2011
September 204199.863 %6.00 %1,199 1,199 
8,371 8,891 
Other borrowings at 1.47%-8.36%, due in fiscal years 2026-2036
826 765 
Fair value adjustment related to hedged debt— (1)
Unamortized debt issuance cost(37)(46)
Current portion of long-term debt(1,292)(788)
Total long-term debt$7,868 $8,821 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
v3.26.1
Stockholders' Deficit (Tables)
9 Months Ended
Jul. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Changes and Reclassifications Related to Other Comprehensive (Loss) Income, Net of Taxes Changes and reclassifications related to Accumulated Other Comprehensive Loss, net of taxes
Three months ended July 31Nine months ended July 31
2026202520262025
In millions
Other comprehensive income (loss), net of taxes:
Unrealized components of available-for-sale debt securities
Balance at the beginning of period$30 $20 $29 $14 
Unrealized gains arising during the period1 5 2 11 
Tax effects on change in unrealized components of available-for-sale securities— (1)— (1)
Unrealized components of available-for-sale debt securities, net of taxes1 4 2 10 
Balance at the end of period$31 $24 $31 $24 
Unrealized components of cash flow hedges
Balance at the beginning of period$(81)$(393)$(48)$47 
Unrealized gains (losses) arising during the period141 59 (6)(301)
Losses reclassified into earnings18 202 119 11 
Tax effects on change in unrealized components of cash flow hedges(28)(61)(15)50 
Unrealized components of cash flow hedges, net of taxes131 200 98 (240)
Balance at the end of period$50 $(193)$50 $(193)
Unrealized components of defined benefit plans
Balance at the beginning of period$(476)$(488)$(450)$(496)
Unrealized gains (losses) arising during the period20 (7)(14)(8)
Amortization of actuarial loss and prior service benefit
5 5 14 15 
Curtailments, settlements and other3 2 5 2 
Tax effects on change in unrealized components of defined benefit plans(4)— (7)(1)
Unrealized components of defined benefit plans, net of taxes24 — (2)8 
Balance at the end of period$(452)$(488)$(452)$(488)
Cumulative translation adjustment
Balance at the beginning of period$26 $18 $12 $1 
Change in cumulative translation adjustment(3)(1)11 16 
Tax effect on change in cumulative translation adjustment— (1)— (1)
Cumulative translation adjustment, net of taxes(3)(2)11 15 
Balance at the end of period$23 $16 $23 $16 
Other comprehensive income (loss)$153 $202 $109 $(207)
Accumulated other comprehensive loss$(348)$(641)$(348)$(641)
v3.26.1
Earnings Per Share (Tables)
9 Months Ended
Jul. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Reconciliation of the Number of Shares Used for Basic and Diluted Net EPS Calculations
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
Three months ended July 31Nine months ended July 31
2026202520262025
In millions, except per share amounts
Numerator:
Net earnings$661 $763 $1,656 $1,734 
Denominator:
Weighted-average shares used to compute basic net EPS919 947 922 948 
Dilutive effect of employee stock plans8 7 5 7 
Weighted-average shares used to compute diluted net EPS927 954 927 955 
Net earnings per share:
Basic$0.72 $0.81 $1.80 $1.83 
Diluted$0.71 $0.80 $1.79 $1.82 
Anti-dilutive weighted-average stock plans(1)
12 14 17 8 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent average unrecognized compensation cost.
v3.26.1
Guarantees, Indemnifications and Warranties (Tables)
9 Months Ended
Jul. 31, 2026
Guarantees [Abstract]  
Schedule of Aggregate Product Warranty Liabilities and Changes
HP’s aggregate product warranty liabilities and changes were as follows:
Nine months ended July 31, 2026
In millions
Balance at beginning of period$452 
Accruals and adjustments468 
Settlements made
(521)
Balance at end of period$399 
v3.26.1
Commitments (Tables)
9 Months Ended
Jul. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Future Unconditional Purchase Obligations
As of July 31, 2026, unconditional purchase obligations were as follows:
Fiscal yearIn millions
2026(1)
$143 
2027619 
2028997 
2029271 
2030104 
Thereafter3 
Total$2,137 
(1)    Represents expected unconditional purchase obligations for the remaining three months of fiscal year 2026.
v3.26.1
Segment Information - Narrative (Details)
$ in Millions
3 Months Ended 9 Months Ended
Jan. 31, 2026
USD ($)
Jul. 31, 2026
segment
Segment Reporting [Abstract]    
Number of reportable segments | segment   3
Printing    
Segment Information    
Goodwill transfered $ 197  
Corporate Investments    
Segment Information    
Goodwill transfered $ (197)  
v3.26.1
Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Net revenue        
Products net revenue $ 15,677 $ 13,932 $ 44,523 $ 40,656
Cost of net revenue        
Total cost of net revenue 12,732 11,081 35,727 32,226
Operating expenses        
Operating expenses 2,053 2,135 6,533 6,215
Segment Reporting, Revenue [Abstract]        
Operating income (loss) 892 716 2,263 2,215
Restructuring and other charges (48) (110) (539) (302)
Acquisition and divestiture charges (4) (8) (6) (31)
Amortization of intangible assets (75) (159) (220) (287)
Interest and other, net (94) (92) (301) (381)
Earnings before taxes 798 624 1,962 1,834
Total segment net revenue        
Net revenue        
Products net revenue 15,679 13,933 44,525 40,658
Cost of net revenue        
Total cost of net revenue 12,725 11,061 35,675 32,145
Operating expenses        
Operating expenses 1,736 1,674 5,112 4,839
Segment Reporting, Revenue [Abstract]        
Operating income (loss) 1,218 1,198 3,738 3,674
Corporate and unallocated costs and other        
Segment Reporting, Revenue [Abstract]        
Corporate and unallocated costs and other (102) (103) (258) (302)
Other        
Net revenue        
Products net revenue (2) (1) (2) (2)
Segment Reporting, Revenue [Abstract]        
Stock-based compensation expense (95) (100) (389) (432)
Restructuring and other charges (48) (110) (539) (302)
Acquisition and divestiture charges (4) (8) (6) (31)
Amortization of intangible assets (75) (159) (220) (287)
Certain litigation charges (2) (2) (63) (105)
Interest and other, net (94) (92) (301) (381)
Personal Systems | Total segment net revenue        
Net revenue        
Products net revenue 11,767 9,931 32,231 28,179
Cost of net revenue        
Total cost of net revenue 10,250 8,421 27,785 24,009
Operating expenses        
Operating expenses 980 969 2,868 2,713
Segment Reporting, Revenue [Abstract]        
Operating income (loss) 537 541 1,578 1,457
Printing | Total segment net revenue        
Net revenue        
Products net revenue 3,912 4,002 12,294 12,479
Cost of net revenue        
Total cost of net revenue 2,475 2,640 7,889 8,134
Operating expenses        
Operating expenses 728 681 2,164 2,059
Segment Reporting, Revenue [Abstract]        
Operating income (loss) 709 681 2,241 2,286
Corporate Investments | Total segment net revenue        
Net revenue        
Products net revenue 0 0 0 0
Cost of net revenue        
Total cost of net revenue 0 0 1 2
Operating expenses        
Operating expenses 28 24 80 67
Segment Reporting, Revenue [Abstract]        
Operating income (loss) (28) (24) (81) (69)
Commercial PS | Personal Systems | Total segment net revenue        
Net revenue        
Products net revenue 8,579 7,036 23,575 20,467
Consumer PS | Personal Systems | Total segment net revenue        
Net revenue        
Products net revenue 3,188 2,895 8,656 7,712
Supplies | Printing | Total segment net revenue        
Net revenue        
Products net revenue 2,536 2,609 8,089 8,166
Commercial Printing | Printing | Total segment net revenue        
Net revenue        
Products net revenue 1,101 1,113 3,374 3,424
Consumer Printing | Printing | Total segment net revenue        
Net revenue        
Products net revenue $ 275 $ 280 $ 831 $ 889
v3.26.1
Restructuring and Other Charges - Schedule of Restructuring and Other Charges (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Restructuring Cost and Reserve [Line Items]        
Restructuring costs $ 48   $ 539  
Fiscal 2026 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs 60   547  
Other prior-year plans        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs (12)   (8)  
Fiscal 2023 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs   $ 110   $ 302
Severance | Fiscal 2026 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs 38   200  
Severance | Fiscal 2023 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs   77   218
Non-labor | Fiscal 2026 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs 7   30  
Non-labor | Fiscal 2023 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs   14   34
Special Termination Benefit | Fiscal 2026 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs 0   280  
Other Charges | Fiscal 2026 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs $ 15   $ 37  
Other Charges | Fiscal 2023 Plan        
Restructuring Cost and Reserve [Line Items]        
Restructuring costs   $ 19   $ 50
v3.26.1
Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details) - USD ($)
$ in Millions
9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Restructuring Reserve [Roll Forward]    
Accrued balance, beginning of the period $ 172 $ 138
Charges 222 252
Cash payments (226) (188)
Non-cash and other adjustments (15) (21)
Accrued balance, end of the period 153 181
Reflected in the Condensed Consolidated Balance Sheets    
Other current liabilities 117  
Other non-current liabilities 36  
Other prior-year plans    
Restructuring Reserve [Roll Forward]    
Accrued balance, beginning of the period 172 138
Charges (8) 252
Cash payments (122) (188)
Non-cash and other adjustments 2 (21)
Accrued balance, end of the period 44 181
Reflected in the Condensed Consolidated Balance Sheets    
Other current liabilities 41  
Other non-current liabilities 3  
Severance | Fiscal 2026 Plan    
Restructuring Reserve [Roll Forward]    
Accrued balance, beginning of the period 0 0
Charges 200 0
Cash payments (91) 0
Non-cash and other adjustments 0 0
Accrued balance, end of the period 109 0
Reflected in the Condensed Consolidated Balance Sheets    
Other current liabilities 76  
Other non-current liabilities 33  
Non-labor | Fiscal 2026 Plan    
Restructuring Reserve [Roll Forward]    
Accrued balance, beginning of the period 0 0
Charges 30 0
Cash payments (13) 0
Non-cash and other adjustments (17) 0
Accrued balance, end of the period 0 $ 0
Reflected in the Condensed Consolidated Balance Sheets    
Other current liabilities 0  
Other non-current liabilities $ 0  
v3.26.1
Restructuring and Other Charges - Narrative (Details)
$ in Millions
1 Months Ended 9 Months Ended
Nov. 25, 2025
USD ($)
employee
Nov. 18, 2022
USD ($)
employee
Jan. 31, 2026
Jul. 31, 2026
USD ($)
Jul. 31, 2025
USD ($)
Restructuring Cost and Reserve [Line Items]          
Eligible age with 10 years of service     55 years    
Charges       $ 222 $ 252
Health care coverage extension period     36 months    
Fiscal 2026 Plan          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related cost, incurred cost       500  
Fiscal 2026 Plan | Labor And Non-Labor Actions          
Restructuring Cost and Reserve [Line Items]          
Estimated pre-tax charges $ 650        
Fiscal 2026 Plan | Labor Costs          
Restructuring Cost and Reserve [Line Items]          
Estimated pre-tax charges $ 500        
Fiscal 2026 Plan | Severance          
Restructuring Cost and Reserve [Line Items]          
Charges       200 $ 0
Fiscal 2023 Plan          
Restructuring Cost and Reserve [Line Items]          
Expected number of positions to be eliminated | employee   9,500      
Restructuring and related cost, incurred cost       1,200  
Fiscal 2023 Plan | Severance costs          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related cost, incurred cost   $ 865      
Fiscal 2023 Plan | Infrastructure costs          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related cost, incurred cost   $ 347      
Enhanced Early Retirement | Special Termination Benefit          
Restructuring Cost and Reserve [Line Items]          
Charges       220  
Other charges       $ 60  
Minimum | Fiscal 2026 Plan          
Restructuring Cost and Reserve [Line Items]          
Expected number of positions to be eliminated | employee 4,000        
Maximum | Fiscal 2026 Plan          
Restructuring Cost and Reserve [Line Items]          
Expected number of positions to be eliminated | employee 6,000        
v3.26.1
Taxes on Earnings (Details)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
USD ($)
country
Jul. 31, 2025
Jul. 31, 2026
USD ($)
country
Jul. 31, 2025
Oct. 31, 2025
USD ($)
Income Tax Disclosure [Abstract]          
Effective tax rate (as a percent) 17.20% (22.30%) 15.60% 5.50%  
Unrecognized tax benefits $ 752   $ 752    
Unrecognized tax benefits that would impact effective tax rate 615   615    
Unrecognized increase (decrease) in tax benefits change     (113)    
Penalties and interest accrued $ 71   $ 71   $ 122
Other countries with income tax jurisdiction | country 60   60    
v3.26.1
Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cash and cash equivalents $ 4,169 $ 3,690
Restricted cash 0 15
Cash, cash equivalents and restricted cash $ 4,169 $ 3,705
v3.26.1
Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details)
$ in Millions
9 Months Ended
Jul. 31, 2026
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Balance at beginning of period $ 83
Current-period allowance for credit losses (18)
Deductions, net of recoveries (8)
Balance at end of period $ 57
v3.26.1
Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Trade Receivables Sold and Cash Received [Roll Forward]        
Balance at beginning of period $ 289 $ 217 $ 117 $ 284
Trade receivables sold 1,729 3,085 7,153 9,259
Cash receipts (2,009) (3,184) (7,264) (9,431)
Foreign currency and other (5) 2 (2) 8
Balance at end of period $ 4 $ 120 $ 4 $ 120
v3.26.1
Supplementary Financial Information - Schedule of Inventory (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finished goods $ 5,958 $ 4,721
Purchased parts and fabricated assemblies 4,364 3,791
Inventory $ 10,322 $ 8,512
v3.26.1
Supplementary Financial Information - Schedule of Other Current Assets (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Supplier and other receivables $ 2,468 $ 1,981
Prepaid and other current assets 1,486 1,577
Value-added taxes receivable 1,133 986
Other current assets $ 5,087 $ 4,544
v3.26.1
Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Property, Plant and Equipment, Net    
Property, plant and equipment, gross $ 8,885 $ 8,486
Accumulated depreciation (5,775) (5,437)
Property, plant and equipment, net 3,110 3,049
Land, buildings and leasehold improvements    
Property, Plant and Equipment, Net    
Property, plant and equipment, gross 2,634 2,619
Machinery and equipment, including equipment held for lease    
Property, Plant and Equipment, Net    
Property, plant and equipment, gross $ 6,251 $ 5,867
v3.26.1
Supplementary Financial Information - Schedule of Other Non-Current Assets (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2026
Oct. 31, 2025
Intangible Asset, Finite-Lived [Line Items]      
Deferred tax assets $ 3,413 $ 3,413 $ 3,318
Right-of-use assets 1,086 1,086 1,129
Intangible assets 802 802 1,012
Prepaid pension and post-retirement benefit assets 220 220 425
Deposits and prepaid 187 187 316
Other 1,411 1,411 1,361
Other non-current assets 7,119 7,119 $ 7,561
Customer Contracts, Customer Lists And Distribution Agreements      
Intangible Asset, Finite-Lived [Line Items]      
Impairment charges $ 23 $ 55  
v3.26.1
Supplementary Financial Information - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Sales and marketing programs $ 3,476 $ 3,103
Deferred revenue 1,761 1,609
Other accrued taxes 1,410 1,258
Employee compensation and benefits 1,272 965
Operating lease liabilities 409 401
Warranty 354 401
Tax liability 101 297
Other 2,505 2,328
Other accrued liabilities $ 11,288 $ 10,362
v3.26.1
Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred revenue $ 1,675 $ 1,632
Operating lease liabilities 770 815
Pension, post-retirement, and post-employment liabilities 552 564
Tax liability 445 496
Deferred tax liability 18 16
Other 502 513
Other non-current liabilities $ 3,962 $ 4,036
v3.26.1
Supplementary Financial Information - Schedule of Interest and Other, Net (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Interest expense on borrowings $ (96) $ (111) $ (293) $ (329)
Factoring costs (16) (32) (61) (101)
Certain litigation benefits 0 52 0 52
Non-operating retirement-related credits 6 3 28 13
Other, net 12 (4) 25 (16)
Interest and other, net $ (94) $ (92) $ (301) $ (381)
v3.26.1
Supplementary Financial Information - Schedule of Net Revenue by Region (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Disaggregation of Revenue [Line Items]        
Total net revenue $ 15,677 $ 13,932 $ 44,523 $ 40,656
Americas        
Disaggregation of Revenue [Line Items]        
Total net revenue 6,486 6,107 17,921 17,419
Europe, Middle East and Africa        
Disaggregation of Revenue [Line Items]        
Total net revenue 5,181 4,502 15,377 13,649
Asia-Pacific and Japan        
Disaggregation of Revenue [Line Items]        
Total net revenue $ 4,010 $ 3,323 $ 11,225 $ 9,588
v3.26.1
Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details)
$ in Billions
Jul. 31, 2026
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 4.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-08-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 2.0
Remaining performance obligations period 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-08-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 2.2
Remaining performance obligations period
v3.26.1
Supplementary Financial Information - Contract Liabilities (Narrative) (Details) - USD ($)
$ in Billions
9 Months Ended
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Contract liability $ 3.4 $ 3.2
Revenue recognized $ 1.2  
v3.26.1
Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details) - USD ($)
$ in Billions
Jul. 31, 2026
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Payment terms offered by HP 30 days  
Obligations outstanding $ 10.9 $ 8.9
Supplier finance program, obligation elected to sell $ 0.0 $ 0.1
v3.26.1
Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Assets    
Cash Equivalents $ 1,412 $ 1,878
Derivative Instruments 210 183
Total assets 1,741 2,195
Liabilities    
Derivative Instruments 169 244
Total liabilities 169 244
Government debt    
Assets    
Cash Equivalents 1,412 1,878
Financial institution instruments    
Assets    
Available-for-Sale Investments 3 3
Marketable securities and mutual funds    
Assets    
Available-for-Sale Investments 116 131
Liabilities    
Debt securities, restricted 46 63
Interest rate contracts    
Liabilities    
Derivative Instruments 0 1
Foreign currency contracts    
Assets    
Derivative Instruments 210 182
Liabilities    
Derivative Instruments 167 242
Other derivatives    
Assets    
Derivative Instruments 0 1
Liabilities    
Derivative Instruments 2 1
Level 1    
Assets    
Total assets 1,423 1,887
Liabilities    
Total liabilities 0 0
Level 1 | Government debt    
Assets    
Cash Equivalents 1,412 1,878
Level 1 | Financial institution instruments    
Assets    
Available-for-Sale Investments 0 0
Level 1 | Marketable securities and mutual funds    
Assets    
Available-for-Sale Investments 11 9
Level 1 | Interest rate contracts    
Liabilities    
Derivative Instruments 0 0
Level 1 | Foreign currency contracts    
Assets    
Derivative Instruments 0 0
Liabilities    
Derivative Instruments 0 0
Level 1 | Other derivatives    
Assets    
Derivative Instruments 0 0
Liabilities    
Derivative Instruments 0 0
Level 2    
Assets    
Total assets 318 308
Liabilities    
Total liabilities 169 244
Level 2 | Government debt    
Assets    
Cash Equivalents 0 0
Level 2 | Financial institution instruments    
Assets    
Available-for-Sale Investments 3 3
Level 2 | Marketable securities and mutual funds    
Assets    
Available-for-Sale Investments 105 122
Level 2 | Interest rate contracts    
Liabilities    
Derivative Instruments 0 1
Level 2 | Foreign currency contracts    
Assets    
Derivative Instruments 210 182
Liabilities    
Derivative Instruments 167 242
Level 2 | Other derivatives    
Assets    
Derivative Instruments 0 1
Liabilities    
Derivative Instruments 2 1
Level 3    
Assets    
Total assets 0 0
Liabilities    
Total liabilities 0 0
Level 3 | Government debt    
Assets    
Cash Equivalents 0 0
Level 3 | Financial institution instruments    
Assets    
Available-for-Sale Investments 0 0
Level 3 | Marketable securities and mutual funds    
Assets    
Available-for-Sale Investments 0 0
Level 3 | Interest rate contracts    
Liabilities    
Derivative Instruments 0 0
Level 3 | Foreign currency contracts    
Assets    
Derivative Instruments 0 0
Liabilities    
Derivative Instruments 0 0
Level 3 | Other derivatives    
Assets    
Derivative Instruments 0 0
Liabilities    
Derivative Instruments $ 0 $ 0
v3.26.1
Fair Value - Narrative (Details) - USD ($)
$ in Billions
Jul. 31, 2026
Oct. 31, 2025
Fair Value Disclosures [Abstract]    
Fair value, short- and long-term debt $ 8.9 $ 9.6
Carrying value, short- and long-term debt $ 9.2 $ 9.7
v3.26.1
Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Cash Equivalents    
Cost $ 1,412 $ 1,878
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,412 1,878
Available-for-Sale Investments    
Cost 92 107
Gross Unrealized Gain 27 27
Gross Unrealized Loss 0 0
Fair Value 119 134
Total cash equivalents and available-for-sale investments, cost 1,504 1,985
Total cash equivalents and available-for-sale investments, gross unrealized gain 27 27
Total cash equivalents and available-for-sale investments, gross unrealized loss 0 0
Total cash equivalents and available-for-sale investments, fair value 1,531 2,012
Government debt    
Cash Equivalents    
Cost 1,412 1,878
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,412 1,878
Financial institution instruments    
Available-for-Sale Investments    
Debt securities, cost 3 3
Debt securities, gross unrealized gain 0 0
Debt securities, gross unrealized loss 0 0
Debt securities, fair value 3 3
Marketable securities and mutual funds    
Available-for-Sale Investments    
Equity securities, cost 89 104
Equity securities, gross unrealized gain 27 27
Equity securities, gross unrealized loss 0 0
Equity securities, fair value 116 131
Debt securities, restricted $ 46 $ 63
v3.26.1
Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details)
$ in Millions
Jul. 31, 2026
USD ($)
Amortized Cost  
Due in one year $ 12
Due in one to five years 35
Amortized Cost 47
Fair Value  
Due in one year 12
Due in one to five years 37
Fair Value $ 49
v3.26.1
Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
9 Months Ended
Jul. 31, 2026
Oct. 31, 2025
Derivatives, Fair Value    
Fair value of derivatives with credit contingent features in a net liability position $ 29 $ 98
Period to collateralize 2 days  
Gain expected to be reclassified from AOCI into earnings in next 12 months $ (21)  
Cash Flow Hedging    
Derivatives, Fair Value    
Foreign currency maturity 12 months  
Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Cost method and other equity investments $ 142 $ 137
v3.26.1
Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Derivatives, Fair Value    
Outstanding Gross Notional $ 21,814 $ 19,299
Derivative instruments, assets 210 183
Derivative instruments, liabilities $ 169 $ 244
Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets
Derivative instruments, assets $ 169 $ 156
Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Derivative instruments, assets $ 41 $ 27
Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Derivative instruments, liabilities $ 152 $ 190
Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
Derivative instruments, liabilities $ 17 $ 54
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 0 250
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 1
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives designated as hedging instruments | Cash flow hedges:    
Derivatives, Fair Value    
Outstanding Gross Notional 17,516 14,742
Derivatives designated as hedging instruments | Cash flow hedges: | Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative instruments, assets 163 141
Derivatives designated as hedging instruments | Cash flow hedges: | Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative instruments, assets 41 27
Derivatives designated as hedging instruments | Cash flow hedges: | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 125 175
Derivatives designated as hedging instruments | Cash flow hedges: | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 17 54
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 17,516 14,492
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative instruments, assets 163 141
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative instruments, assets 41 27
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 125 174
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 17 54
Derivatives not designated as hedging instruments    
Derivatives, Fair Value    
Outstanding Gross Notional 4,298 4,557
Derivatives not designated as hedging instruments | Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative instruments, assets 6 15
Derivatives not designated as hedging instruments | Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 27 15
Derivatives not designated as hedging instruments | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives not designated as hedging instruments | Foreign currency contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 4,132 4,389
Derivatives not designated as hedging instruments | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative instruments, assets 6 14
Derivatives not designated as hedging instruments | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 25 14
Derivatives not designated as hedging instruments | Foreign currency contracts | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives not designated as hedging instruments | Other derivatives    
Derivatives, Fair Value    
Outstanding Gross Notional 166 168
Derivatives not designated as hedging instruments | Other derivatives | Balance Sheet Location [Axis]: us-gaap:OtherAssetsCurrent    
Derivatives, Fair Value    
Derivative instruments, assets 0 1
Derivatives not designated as hedging instruments | Other derivatives | Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Other derivatives | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesCurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities 2 1
Derivatives not designated as hedging instruments | Other derivatives | Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent    
Derivatives, Fair Value    
Derivative instruments, liabilities $ 0 $ 0
v3.26.1
Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details) - USD ($)
$ in Millions
9 Months Ended
Jul. 31, 2026
Oct. 31, 2025
Derivative assets    
Gross Amount Recognized $ 210 $ 183
Gross Amount Offset 0 0
Net Amount Presented 210 183
Gross Amounts Not Offset    
Derivatives 133 143
Financial Collateral 162 15
Net Amount (85) 25
Derivative liabilities    
Gross Amount Recognized 169 244
Gross Amount Offset 0 0
Net Amount Presented 169 244
Gross Amounts Not Offset    
Derivatives 133 143
Financial Collateral 328 279
Net Amount $ (292) $ (178)
Period to collateralize 2 days  
v3.26.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details) - Interest rate contracts - Income Statement Location [Axis]: us-gaap:NonoperatingIncomeExpense - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instruments $ 0 $ 2 $ 1 $ 17
Gain/(loss) recognized in earnings on hedged item $ 0 $ (2) $ (1) $ (17)
v3.26.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized gains (losses) arising during the period $ 141 $ 59 $ (6) $ (301)
Cash flow hedges:        
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized gains (losses) arising during the period 141 59 (6) (301)
Foreign currency contracts | Cash flow hedges:        
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized gains (losses) arising during the period 141 59 (6) (304)
Interest rate contracts | Cash flow hedges:        
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized gains (losses) arising during the period $ 0 $ 0 $ 0 $ 3
v3.26.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Pre-tax effect of derivative instruments in cash flow hedging relationships        
(Loss)/gain reclassified from Accumulated  other comprehensive (loss) income into earnings $ (18) $ (202) $ (119) $ (11)
Cash flow hedges:        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
(Loss)/gain reclassified from Accumulated  other comprehensive (loss) income into earnings (18) (202) (119) (11)
Cash flow hedges: | Income Statement Location [Axis]: us-gaap:CostOfRevenue        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
(Loss)/gain reclassified from Accumulated  other comprehensive (loss) income into earnings (13) (21) (37) (71)
Cash flow hedges: | Income Statement Location [Axis]: us-gaap:CostsAndExpenses        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
(Loss)/gain reclassified from Accumulated  other comprehensive (loss) income into earnings 3 0 7 1
Cash flow hedges: | Income Statement Location [Axis]: us-gaap:NonoperatingIncomeExpense        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
(Loss)/gain reclassified from Accumulated  other comprehensive (loss) income into earnings 4 3 12 9
Cash flow hedges: | Income Statement Location [Axis]: us-gaap:Revenues        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
(Loss)/gain reclassified from Accumulated  other comprehensive (loss) income into earnings $ (12) $ (184) $ (101) $ 50
v3.26.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instrument $ (43) $ 4 $ (42) $ (5)
Income Statement Location [Axis]: us-gaap:NonoperatingIncomeExpense | Foreign currency contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instrument (32) 7 (39) (7)
Income Statement Location [Axis]: us-gaap:NonoperatingIncomeExpense | Other derivatives        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instrument $ (11) $ (3) $ (3) $ 2
v3.26.1
Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details) - USD ($)
$ in Millions
Jul. 31, 2026
Oct. 31, 2025
Amount Outstanding    
Current portion of long-term debt $ 1,292 $ 788
Notes payable to banks and other $ 1,292 $ 845
Weighted-Average Interest Rate    
Current portion of long-term debt 4.10% 3.20%
Notes payable to banks and other    
Amount Outstanding    
Notes payable to banks and other $ 0 $ 57
Weighted-Average Interest Rate    
Notes payable to banks and other 0.00% 0.00%
v3.26.1
Borrowings - Schedule of Long-Term Debt (Details) - USD ($)
Jul. 31, 2026
Oct. 31, 2025
Long-term debt    
Fair value adjustment related to hedged debt $ 0 $ (1,000,000)
Unamortized debt issuance cost (37,000,000) (46,000,000)
Current portion of long-term debt (1,292,000,000) (788,000,000)
Total long-term debt 7,868,000,000 8,821,000,000
U.S. Dollar Global Notes    
Long-term debt    
Long-term debt 8,371,000,000 8,891,000,000
$1,000 issued June 2021    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.808%  
Interest rate (percent) 1.45%  
Long-term debt $ 0 522,000,000
$1,000 issued June 2020    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.718%  
Interest rate (percent) 3.00%  
Long-term debt $ 1,000,000,000 999,000,000
$900 issued June 2022    
Long-term debt    
Face amount of debt instrument $ 900,000,000  
Discount to par (percent) 99.841%  
Interest rate (percent) 4.75%  
Long-term debt $ 900,000,000 899,000,000
$1,000 issued March 2022    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.767%  
Interest rate (percent) 4.00%  
Long-term debt $ 999,000,000 999,000,000
$500 issued April 2025    
Long-term debt    
Face amount of debt instrument $ 500,000,000  
Discount to par (percent) 99.732%  
Interest rate (percent) 5.40%  
Long-term debt $ 499,000,000 499,000,000
$850 issued June 2020    
Long-term debt    
Face amount of debt instrument $ 850,000,000  
Discount to par (percent) 99.79%  
Interest rate (percent) 3.40%  
Long-term debt $ 503,000,000 503,000,000
$1,000 issued June 2021    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.573%  
Interest rate (percent) 2.65%  
Long-term debt $ 998,000,000 998,000,000
$1,000 issued March 2022    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.966%  
Interest rate (percent) 4.20%  
Long-term debt $ 676,000,000 676,000,000
$1,100 issued June 2022    
Long-term debt    
Face amount of debt instrument $ 1,100,000,000  
Discount to par (percent) 99.725%  
Interest rate (percent) 5.50%  
Long-term debt $ 1,098,000,000 1,098,000,000
$500 issued April 2025    
Long-term debt    
Face amount of debt instrument $ 500,000,000  
Discount to par (percent) 99.778%  
Interest rate (percent) 6.10%  
Long-term debt $ 499,000,000 499,000,000
$1,200 issued September 2011    
Long-term debt    
Face amount of debt instrument $ 1,200,000,000  
Discount to par (percent) 99.863%  
Interest rate (percent) 6.00%  
Long-term debt $ 1,199,000,000 1,199,000,000
Other borrowings at 1.47%-8.36%, due in fiscal years 2026-2036    
Long-term debt    
Other borrowings at 1.47%-8.36%, due in fiscal years 2026-2036 $ 826,000,000 $ 765,000,000
Other borrowings at 1.47%-8.36%, due in fiscal years 2026-2036 | Minimum    
Long-term debt    
Interest rate (percent) 1.47%  
Other borrowings at 1.47%-8.36%, due in fiscal years 2026-2036 | Maximum    
Long-term debt    
Interest rate (percent) 8.36%  
v3.26.1
Borrowings - Narrative (Details)
9 Months Ended
Jul. 31, 2026
USD ($)
Commercial Paper  
Line of Credit Facility [Line Items]  
Maximum borrowing capacity under credit facility $ 6,000,000,000.0
Credit Facilities  
Line of Credit Facility [Line Items]  
Available borrowing resources 900,000,000
New Revolving Facility | Revolving Credit Facility  
Line of Credit Facility [Line Items]  
Maximum borrowing capacity under credit facility $ 5,000,000,000.0
Revolving credit facility, term 5 years
Line of credit amount outstanding $ 0
v3.26.1
Stockholders' Deficit - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Stockholders' Equity Note [Abstract]        
Repurchases of common stock (in shares) 12.2 5.5 30.5 11.4
Payment in connection with repurchases of shares $ 300 $ 200 $ 725 $ 350
Shares settled (in shares)   0.3   0.3
Share repurchase authorization remaining $ 7,700   $ 7,700  
v3.26.1
Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Apr. 30, 2026
Jan. 31, 2026
Jul. 31, 2025
Apr. 30, 2025
Jan. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Components of accumulated other comprehensive income, net of taxes                
Balance at the beginning of period $ (144) $ (766) $ (346) $ (1,276) $ (1,072) $ (1,323) $ (346) $ (1,323)
Tax effects on change in unrealized components (32)     (63)     (22) 47
Other comprehensive income (loss), net of taxes 153 153 (197) 202 (639) 230 109 (207)
Balance at the end of period (92) (144) (766) (901) (1,276) (1,072) (92) (901)
Unrealized components of available-for-sale debt securities                
Components of accumulated other comprehensive income, net of taxes                
Balance at the beginning of period 30   29 20   14 29 14
Unrealized gains (losses) arising during the period 1     5     2 11
Tax effects on change in unrealized components 0     (1)     0 (1)
Other comprehensive income (loss), net of taxes 1     4     2 10
Balance at the end of period 31 30   24 20   31 24
Unrealized components of cash flow hedges                
Components of accumulated other comprehensive income, net of taxes                
Balance at the beginning of period (81)   (48) (393)   47 (48) 47
Unrealized gains (losses) arising during the period 141     59     (6) (301)
Losses reclassified into earnings 18     202     119 11
Tax effects on change in unrealized components (28)     (61)     (15) 50
Other comprehensive income (loss), net of taxes 131     200     98 (240)
Balance at the end of period 50 (81)   (193) (393)   50 (193)
Unrealized components of defined benefit plans                
Components of accumulated other comprehensive income, net of taxes                
Balance at the beginning of period (476)   (450) (488)   (496) (450) (496)
Unrealized gains (losses) arising during the period 20     (7)     (14) (8)
Tax effects on change in unrealized components (4)     0     (7) (1)
Other comprehensive income (loss), net of taxes 24     0     (2) 8
Balance at the end of period (452) (476)   (488) (488)   (452) (488)
Amortization of actuarial loss and prior service benefit                
Components of accumulated other comprehensive income, net of taxes                
Losses reclassified into earnings (5)     (5)     (14) (15)
Curtailments, settlements and other                
Components of accumulated other comprehensive income, net of taxes                
Losses reclassified into earnings 3     2     5 2
Cumulative translation adjustment                
Components of accumulated other comprehensive income, net of taxes                
Balance at the beginning of period 26   12 18   1 12 1
Unrealized gains (losses) arising during the period (3)     (1)     11 16
Tax effects on change in unrealized components 0     (1)     0 (1)
Other comprehensive income (loss), net of taxes (3)     (2)     11 15
Balance at the end of period 23 26   16 18   23 16
Accumulated other comprehensive loss                
Components of accumulated other comprehensive income, net of taxes                
Balance at the beginning of period (501) (654) (457) (843) (204) (434) (457) (434)
Other comprehensive income (loss), net of taxes 153 153 (197) 202 (639) 230    
Balance at the end of period $ (348) $ (501) $ (654) $ (641) $ (843) $ (204) $ (348) $ (641)
v3.26.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Numerator:        
Net earnings, basic $ 661 $ 763 $ 1,656 $ 1,734
Net earnings, diluted $ 661 $ 763 $ 1,656 $ 1,734
Denominator:        
Weighted-average shares used to compute basic net EPS (in shares) 919 947 922 948
Dilutive effect of employee stock plans (in shares) 8 7 5 7
Weighted-average shares used to compute diluted net EPS (in shares) 927 954 927 955
Net earnings per share:        
Basic (usd per share) $ 0.72 $ 0.81 $ 1.80 $ 1.83
Diluted (usd per share) $ 0.71 $ 0.80 $ 1.79 $ 1.82
Anti-dilutive weighted-average stock plans (in shares) 12 14 17 8
v3.26.1
Litigation and Contingencies (Details)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 24, 2026
USD ($)
Jul. 22, 2025
USD ($)
May 10, 2010
USD ($)
employee
Aug. 26, 2026
USD ($)
Feb. 29, 2024
USD ($)
Oct. 31, 2020
patent
Sep. 30, 2020
patent
Jul. 31, 2026
USD ($)
Jul. 31, 2026
USD ($)
Dec. 31, 2015
subsidiary
employee
Apr. 20, 2012
USD ($)
Apr. 11, 2012
USD ($)
Litigation and Contingencies                        
Aggregate damages sought         $ 4,000              
Loss contingency, damages awarded, value $ 1,240 $ 740                    
IEEPA Tariff Refund                        
Litigation and Contingencies                        
Tariff refund claims submitted               $ 300 $ 300      
Refund received               $ 127 $ 127      
IEEPA Tariff Refund | Subsequent event                        
Litigation and Contingencies                        
Refund received       $ 91                
Philips Patent Litigation                        
Litigation and Contingencies                        
Patents allegedly infringed | patent             4          
Patents withdrawn | patent           2            
India Directorate of Revenue Intelligence Proceedings                        
Litigation and Contingencies                        
Number of current employees | employee     7                  
Number of former employee | employee     1                  
Aggregate damages sought     $ 370                  
Duties and penalties under show cause notices                     $ 17 $ 386
Autonomy-Related Legal Matters | Autonomy                        
Litigation and Contingencies                        
Number of subsidiaries | subsidiary                   4    
Number of members | employee                   2    
v3.26.1
Guarantees, Indemnifications and Warranties (Details)
$ in Millions
9 Months Ended
Jul. 31, 2026
USD ($)
Changes in aggregated product warranty liabilities  
Balance at beginning of period $ 452
Accruals and adjustments 468
Settlements made (521)
Balance at end of period $ 399
v3.26.1
Commitments (Details)
$ in Millions
Jul. 31, 2026
USD ($)
Fiscal year  
2026 $ 143
2027 619
2028 997
2029 271
2030 104
Thereafter 3
Total $ 2,137
v3.26.1
Commitments - Narrative (Details)
$ in Billions
Oct. 31, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Purchase obligation $ 1.1